JP2006265187A - Emulsified agent for hair treatment - Google Patents
Emulsified agent for hair treatment Download PDFInfo
- Publication number
- JP2006265187A JP2006265187A JP2005087141A JP2005087141A JP2006265187A JP 2006265187 A JP2006265187 A JP 2006265187A JP 2005087141 A JP2005087141 A JP 2005087141A JP 2005087141 A JP2005087141 A JP 2005087141A JP 2006265187 A JP2006265187 A JP 2006265187A
- Authority
- JP
- Japan
- Prior art keywords
- mercapto
- hair treatment
- polyoxyethylene
- hair
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000011282 treatment Methods 0.000 title claims abstract description 73
- -1 cyclic mercapto compound Chemical class 0.000 claims abstract description 171
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 102
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 41
- 239000004094 surface-active agent Substances 0.000 claims abstract description 26
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 87
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 claims description 30
- SUWCVSZZLFOSJL-UHFFFAOYSA-N 3-sulfanyloxolan-2-one Chemical compound SC1CCOC1=O SUWCVSZZLFOSJL-UHFFFAOYSA-N 0.000 claims description 24
- 238000012545 processing Methods 0.000 claims description 24
- 150000001875 compounds Chemical class 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 21
- 239000000126 substance Substances 0.000 claims description 19
- 239000002736 nonionic surfactant Substances 0.000 claims description 13
- 229940079593 drug Drugs 0.000 claims description 12
- 239000003814 drug Substances 0.000 claims description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 12
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 12
- 125000002947 alkylene group Chemical group 0.000 claims description 11
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- 239000003638 chemical reducing agent Substances 0.000 claims description 10
- 125000004432 carbon atom Chemical group C* 0.000 claims description 8
- 229920001296 polysiloxane Polymers 0.000 claims description 8
- 150000005215 alkyl ethers Chemical class 0.000 claims description 7
- 239000003876 biosurfactant Substances 0.000 claims description 7
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 7
- KQMHPBZASSQUOI-UHFFFAOYSA-N 5-methyl-3-sulfanyloxolan-2-one Chemical compound CC1CC(S)C(=O)O1 KQMHPBZASSQUOI-UHFFFAOYSA-N 0.000 claims description 5
- 239000003093 cationic surfactant Substances 0.000 claims description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- JUHNSCTZYIBZNP-UHFFFAOYSA-N 5-ethyl-3-sulfanyloxolan-2-one Chemical compound CCC1CC(S)C(=O)O1 JUHNSCTZYIBZNP-UHFFFAOYSA-N 0.000 claims description 4
- 239000002280 amphoteric surfactant Substances 0.000 claims description 4
- 239000003945 anionic surfactant Substances 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 4
- 229910052717 sulfur Inorganic materials 0.000 claims description 4
- 125000004434 sulfur atom Chemical group 0.000 claims description 4
- ZSVVABYVFGHFGR-UHFFFAOYSA-N 3-sulfanylazepan-2-one Chemical compound SC1CCCCNC1=O ZSVVABYVFGHFGR-UHFFFAOYSA-N 0.000 claims description 3
- 108010028921 Lipopeptides Proteins 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 6
- 230000009467 reduction Effects 0.000 abstract description 4
- 239000002244 precipitate Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 description 44
- 239000012085 test solution Substances 0.000 description 34
- 238000012360 testing method Methods 0.000 description 20
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 17
- 235000014113 dietary fatty acids Nutrition 0.000 description 16
- 239000000194 fatty acid Substances 0.000 description 16
- 229930195729 fatty acid Natural products 0.000 description 16
- 239000000243 solution Substances 0.000 description 16
- 239000004359 castor oil Substances 0.000 description 15
- 235000019438 castor oil Nutrition 0.000 description 15
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 15
- 238000002360 preparation method Methods 0.000 description 15
- 239000000203 mixture Substances 0.000 description 14
- 230000000694 effects Effects 0.000 description 13
- 230000000052 comparative effect Effects 0.000 description 12
- 239000008213 purified water Substances 0.000 description 12
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 11
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 11
- 150000004665 fatty acids Chemical class 0.000 description 11
- 239000000523 sample Substances 0.000 description 11
- 230000008859 change Effects 0.000 description 9
- 238000000354 decomposition reaction Methods 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 9
- 102000011782 Keratins Human genes 0.000 description 8
- 108010076876 Keratins Proteins 0.000 description 8
- 230000002378 acidificating effect Effects 0.000 description 8
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Polymers OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 8
- 230000007935 neutral effect Effects 0.000 description 8
- 150000002148 esters Chemical class 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical class CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 5
- 239000004166 Lanolin Substances 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 230000015556 catabolic process Effects 0.000 description 5
- 238000004040 coloring Methods 0.000 description 5
- 238000006731 degradation reaction Methods 0.000 description 5
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 229940039717 lanolin Drugs 0.000 description 5
- 235000019388 lanolin Nutrition 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- JPPRXACMNPYJNK-UHFFFAOYSA-N 1-docosoxydocosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCCCCCC JPPRXACMNPYJNK-UHFFFAOYSA-N 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical group CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 4
- 206010070834 Sensitisation Diseases 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 229910052751 metal Chemical class 0.000 description 4
- 239000002184 metal Chemical class 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 230000036961 partial effect Effects 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 238000003672 processing method Methods 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 230000008313 sensitization Effects 0.000 description 4
- 230000036556 skin irritation Effects 0.000 description 4
- 231100000475 skin irritation Toxicity 0.000 description 4
- 239000000600 sorbitol Substances 0.000 description 4
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 3
- 239000004475 Arginine Chemical group 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Chemical group NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- 239000004472 Lysine Chemical group 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Chemical group OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003240 coconut oil Substances 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 3
- 235000018417 cysteine Nutrition 0.000 description 3
- 229960002433 cysteine Drugs 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 150000002366 halogen compounds Chemical class 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 150000002596 lactones Chemical class 0.000 description 3
- 229960003136 leucine Drugs 0.000 description 3
- 229960003151 mercaptamine Drugs 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 229920001451 polypropylene glycol Polymers 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000002453 shampoo Substances 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- 229960004295 valine Drugs 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 2
- PMNLUUOXGOOLSP-UHFFFAOYSA-N 2-mercaptopropanoic acid Chemical compound CC(S)C(O)=O PMNLUUOXGOOLSP-UHFFFAOYSA-N 0.000 description 2
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 2
- CLQRIONWPXOGGK-UHFFFAOYSA-N 3-sulfanyloxan-2-one Chemical compound SC1CCCOC1=O CLQRIONWPXOGGK-UHFFFAOYSA-N 0.000 description 2
- CLWUQJHGNOFQHQ-UHFFFAOYSA-N 3-sulfanylpiperidin-2-one Chemical compound SC1CCCNC1=O CLWUQJHGNOFQHQ-UHFFFAOYSA-N 0.000 description 2
- FHPVNTBXCQPWDY-UHFFFAOYSA-N 3-sulfanylpyrrolidin-2-one Chemical compound SC1CCNC1=O FHPVNTBXCQPWDY-UHFFFAOYSA-N 0.000 description 2
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 2
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000195940 Bryophyta Species 0.000 description 2
- AFWTZXXDGQBIKW-UHFFFAOYSA-N C14 surfactin Natural products CCCCCCCCCCCC1CC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1 AFWTZXXDGQBIKW-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Chemical group OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical group NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical group NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical group OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical group OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical group CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical group NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 239000004264 Petrolatum Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical group CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- FGUZFFWTBWJBIL-XWVZOOPGSA-N [(1r)-1-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O FGUZFFWTBWJBIL-XWVZOOPGSA-N 0.000 description 2
- IJCWFDPJFXGQBN-RYNSOKOISA-N [(2R)-2-[(2R,3R,4S)-4-hydroxy-3-octadecanoyloxyoxolan-2-yl]-2-octadecanoyloxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCCCC IJCWFDPJFXGQBN-RYNSOKOISA-N 0.000 description 2
- 229960004308 acetylcysteine Drugs 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 125000005037 alkyl phenyl group Chemical group 0.000 description 2
- 150000008051 alkyl sulfates Chemical class 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Chemical group OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- GNVMUORYQLCPJZ-UHFFFAOYSA-N carbamothioic s-acid Chemical compound NC(S)=O GNVMUORYQLCPJZ-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 229960003067 cystine Drugs 0.000 description 2
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 2
- YIOJGTBNHQAVBO-UHFFFAOYSA-N dimethyl-bis(prop-2-enyl)azanium Chemical compound C=CC[N+](C)(C)CC=C YIOJGTBNHQAVBO-UHFFFAOYSA-N 0.000 description 2
- 125000002228 disulfide group Chemical group 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Chemical group 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000003700 hair damage Effects 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Chemical group CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 150000003951 lactams Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 2
- 235000011929 mousse Nutrition 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 229940066842 petrolatum Drugs 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- XUXNAKZDHHEHPC-UHFFFAOYSA-M sodium bromate Chemical compound [Na+].[O-]Br(=O)=O XUXNAKZDHHEHPC-UHFFFAOYSA-M 0.000 description 2
- 229940057429 sorbitan isostearate Drugs 0.000 description 2
- 229940035044 sorbitan monolaurate Drugs 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- 235000011078 sorbitan tristearate Nutrition 0.000 description 2
- 239000001589 sorbitan tristearate Substances 0.000 description 2
- 229960004129 sorbitan tristearate Drugs 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- NJGWOFRZMQRKHT-UHFFFAOYSA-N surfactin Natural products CC(C)CCCCCCCCCC1CC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1 NJGWOFRZMQRKHT-UHFFFAOYSA-N 0.000 description 2
- NJGWOFRZMQRKHT-WGVNQGGSSA-N surfactin C Chemical class CC(C)CCCCCCCCC[C@@H]1CC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O1 NJGWOFRZMQRKHT-WGVNQGGSSA-N 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 239000004474 valine Chemical group 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical group OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 1
- PAFJZWHXMSQJKV-UQZRNVAESA-N (3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol;octadecanoic acid Chemical compound OC[C@@H](O)C1OC[C@H](O)[C@H]1O.OC[C@@H](O)C1OC[C@H](O)[C@H]1O.OC[C@@H](O)C1OC[C@H](O)[C@H]1O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O PAFJZWHXMSQJKV-UQZRNVAESA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Chemical group OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- RECMXJOGNNTEBG-UHFFFAOYSA-N 1-phenylmethoxyethanol Chemical compound CC(O)OCC1=CC=CC=C1 RECMXJOGNNTEBG-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- DLLMHEDYJQACRM-UHFFFAOYSA-N 2-(carboxymethyldisulfanyl)acetic acid Chemical compound OC(=O)CSSCC(O)=O DLLMHEDYJQACRM-UHFFFAOYSA-N 0.000 description 1
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- HGERVGNIOOOLBD-UHFFFAOYSA-N 2-hydroxy-2-sulfanylacetamide Chemical class NC(=O)C(O)S HGERVGNIOOOLBD-UHFFFAOYSA-N 0.000 description 1
- IDKCNFVOEYDNTN-UHFFFAOYSA-N 2-hydroxy-2-sulfanylpropanamide Chemical class CC(O)(S)C(N)=O IDKCNFVOEYDNTN-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- IBSYLGXDFSJKQP-UHFFFAOYSA-N 3,4-dimethyl-3-sulfanylazetidin-2-one Chemical compound CC1NC(=O)C1(C)S IBSYLGXDFSJKQP-UHFFFAOYSA-N 0.000 description 1
- AQBCEKGHWGAVRG-UHFFFAOYSA-N 3,4-dimethyl-3-sulfanyloxetan-2-one Chemical compound CC1OC(=O)C1(C)S AQBCEKGHWGAVRG-UHFFFAOYSA-N 0.000 description 1
- JKKATRCFEBLJKZ-UHFFFAOYSA-N 3,5,5-trimethyl-3-sulfanyloxolan-2-one Chemical compound CC1(C)CC(C)(S)C(=O)O1 JKKATRCFEBLJKZ-UHFFFAOYSA-N 0.000 description 1
- CDOUZKKFHVEKRI-UHFFFAOYSA-N 3-bromo-n-[(prop-2-enoylamino)methyl]propanamide Chemical compound BrCCC(=O)NCNC(=O)C=C CDOUZKKFHVEKRI-UHFFFAOYSA-N 0.000 description 1
- LFJJGHGXHXXDFT-UHFFFAOYSA-N 3-bromooxolan-2-one Chemical compound BrC1CCOC1=O LFJJGHGXHXXDFT-UHFFFAOYSA-N 0.000 description 1
- QVDXKUWUFFNTQC-UHFFFAOYSA-N 3-ethyl-3-sulfanyloxan-2-one Chemical compound CCC1(S)CCCOC1=O QVDXKUWUFFNTQC-UHFFFAOYSA-N 0.000 description 1
- NNKBDNPVIVVROG-UHFFFAOYSA-N 3-ethyl-3-sulfanyloxolan-2-one Chemical compound CCC1(S)CCOC1=O NNKBDNPVIVVROG-UHFFFAOYSA-N 0.000 description 1
- XWKUTQRGUGVSDX-UHFFFAOYSA-N 3-ethyl-3-sulfanylpyrrolidin-2-one Chemical compound CCC1(S)CCNC1=O XWKUTQRGUGVSDX-UHFFFAOYSA-N 0.000 description 1
- OROGUZVNAFJPHA-UHFFFAOYSA-N 3-hydroxy-2,4-dimethyl-2H-thiophen-5-one Chemical compound CC1SC(=O)C(C)=C1O OROGUZVNAFJPHA-UHFFFAOYSA-N 0.000 description 1
- AUVUSSJIRFUIML-UHFFFAOYSA-N 3-methyl-3-sulfanylazepan-2-one Chemical compound CC1(S)CCCCNC1=O AUVUSSJIRFUIML-UHFFFAOYSA-N 0.000 description 1
- CLTGBFJFXWONSF-UHFFFAOYSA-N 3-methyl-3-sulfanylazetidin-2-one Chemical compound CC1(S)CNC1=O CLTGBFJFXWONSF-UHFFFAOYSA-N 0.000 description 1
- YSKNOJWNRKKCHM-UHFFFAOYSA-N 3-methyl-3-sulfanyloxan-2-one Chemical compound CC1(S)CCCOC1=O YSKNOJWNRKKCHM-UHFFFAOYSA-N 0.000 description 1
- YWTGQAILIYNNEM-UHFFFAOYSA-N 3-methyl-3-sulfanyloxepan-2-one Chemical compound CC1(S)CCCCOC1=O YWTGQAILIYNNEM-UHFFFAOYSA-N 0.000 description 1
- PAJYSXAQEXSOMV-UHFFFAOYSA-N 3-methyl-3-sulfanyloxetan-2-one Chemical compound CC1(S)COC1=O PAJYSXAQEXSOMV-UHFFFAOYSA-N 0.000 description 1
- QXLWMAAKBIMGKX-UHFFFAOYSA-N 3-methyl-3-sulfanyloxolan-2-one Chemical compound CC1(S)CCOC1=O QXLWMAAKBIMGKX-UHFFFAOYSA-N 0.000 description 1
- XDLODNVPWISWER-UHFFFAOYSA-N 3-methyl-3-sulfanylpiperidin-2-one Chemical compound CC1(S)CCCNC1=O XDLODNVPWISWER-UHFFFAOYSA-N 0.000 description 1
- ULSDLJZZONGVLE-UHFFFAOYSA-N 3-methyl-3-sulfanylpyrrolidin-2-one Chemical compound CC1(S)CCNC1=O ULSDLJZZONGVLE-UHFFFAOYSA-N 0.000 description 1
- PGRWJRXHGTWDCN-UHFFFAOYSA-N 3-sulfanylazetidin-2-one Chemical compound SC1CNC1=O PGRWJRXHGTWDCN-UHFFFAOYSA-N 0.000 description 1
- YTJCHVPWSCENEB-UHFFFAOYSA-N 3-sulfanylazocan-2-one Chemical compound SC1CCCCCNC1=O YTJCHVPWSCENEB-UHFFFAOYSA-N 0.000 description 1
- HNERNHIOSFQJIE-UHFFFAOYSA-N 3-sulfanylazonan-2-one Chemical compound SC1CCCCCCNC1=O HNERNHIOSFQJIE-UHFFFAOYSA-N 0.000 description 1
- GKVJOWXPGSDDQP-UHFFFAOYSA-N 3-sulfanyloxepan-2-one Chemical compound SC1CCCCOC1=O GKVJOWXPGSDDQP-UHFFFAOYSA-N 0.000 description 1
- YROOSZGMFVWENY-UHFFFAOYSA-N 3-sulfanyloxetan-2-one Chemical compound SC1COC1=O YROOSZGMFVWENY-UHFFFAOYSA-N 0.000 description 1
- LDRXXDCBSOYNQD-UHFFFAOYSA-N 3-sulfanyloxocan-2-one Chemical compound SC1CCCCCOC1=O LDRXXDCBSOYNQD-UHFFFAOYSA-N 0.000 description 1
- HLTMYUSLUHVYEP-UHFFFAOYSA-N 3-sulfanyloxolan-2-one Chemical compound SC1CCOC1=O.SC1CCOC1=O HLTMYUSLUHVYEP-UHFFFAOYSA-N 0.000 description 1
- PTLFMRDUTDSDCG-UHFFFAOYSA-N 3-sulfanyloxonan-2-one Chemical compound SC1CCCCCCOC1=O PTLFMRDUTDSDCG-UHFFFAOYSA-N 0.000 description 1
- RBNJFMZERMPTKT-UHFFFAOYSA-N 4,5-dimethyl-3-sulfanyloxolan-2-one Chemical compound CC1OC(=O)C(S)C1C RBNJFMZERMPTKT-UHFFFAOYSA-N 0.000 description 1
- YXIQXACPMRDZSJ-UHFFFAOYSA-N 4,5-dimethyl-3-sulfanylpyrrolidin-2-one Chemical compound CC1NC(=O)C(S)C1C YXIQXACPMRDZSJ-UHFFFAOYSA-N 0.000 description 1
- HJSBLKOEGOPDTP-UHFFFAOYSA-N 4-ethyl-3-sulfanylazetidin-2-one Chemical compound CCC1NC(=O)C1S HJSBLKOEGOPDTP-UHFFFAOYSA-N 0.000 description 1
- SXWCMGHTBBURIK-UHFFFAOYSA-N 4-ethyl-3-sulfanyloxan-2-one Chemical compound CCC1CCOC(=O)C1S SXWCMGHTBBURIK-UHFFFAOYSA-N 0.000 description 1
- QDLKRMVARHTEBR-UHFFFAOYSA-N 4-ethyl-3-sulfanyloxetan-2-one Chemical compound CCC1OC(=O)C1S QDLKRMVARHTEBR-UHFFFAOYSA-N 0.000 description 1
- LPDKGTYUKGZXEI-UHFFFAOYSA-N 4-ethyl-3-sulfanyloxolan-2-one Chemical compound CCC1COC(=O)C1S LPDKGTYUKGZXEI-UHFFFAOYSA-N 0.000 description 1
- QIWBHACJAYLDOK-UHFFFAOYSA-N 4-ethyl-3-sulfanylpiperidin-2-one Chemical compound CCC1CCNC(=O)C1S QIWBHACJAYLDOK-UHFFFAOYSA-N 0.000 description 1
- VAVKMRVVLKQIMD-UHFFFAOYSA-N 4-ethyl-3-sulfanylpyrrolidin-2-one Chemical compound CCC1CNC(=O)C1S VAVKMRVVLKQIMD-UHFFFAOYSA-N 0.000 description 1
- GAXRGOKZEZJNJU-UHFFFAOYSA-N 4-methyl-3-sulfanylazepan-2-one Chemical compound CC1CCCNC(=O)C1S GAXRGOKZEZJNJU-UHFFFAOYSA-N 0.000 description 1
- ALNATYNVBQVNCJ-UHFFFAOYSA-N 4-methyl-3-sulfanylazetidin-2-one Chemical compound CC1NC(=O)C1S ALNATYNVBQVNCJ-UHFFFAOYSA-N 0.000 description 1
- JQLMOROGCVWWDU-UHFFFAOYSA-N 4-methyl-3-sulfanyloxan-2-one Chemical compound CC1CCOC(=O)C1S JQLMOROGCVWWDU-UHFFFAOYSA-N 0.000 description 1
- IRHBEWGTAXGGHX-UHFFFAOYSA-N 4-methyl-3-sulfanyloxepan-2-one Chemical compound CC1CCCOC(=O)C1S IRHBEWGTAXGGHX-UHFFFAOYSA-N 0.000 description 1
- XZPOTZZMVXQIAV-UHFFFAOYSA-N 4-methyl-3-sulfanyloxetan-2-one Chemical compound CC1OC(=O)C1S XZPOTZZMVXQIAV-UHFFFAOYSA-N 0.000 description 1
- GOMCETYIICWVLL-UHFFFAOYSA-N 4-methyl-3-sulfanyloxolan-2-one Chemical compound CC1COC(=O)C1S GOMCETYIICWVLL-UHFFFAOYSA-N 0.000 description 1
- VUBBGNUDBTUNEX-UHFFFAOYSA-N 4-methyl-3-sulfanylpiperidin-2-one Chemical compound CC1CCNC(=O)C1S VUBBGNUDBTUNEX-UHFFFAOYSA-N 0.000 description 1
- HPZWRPBETAXFQZ-UHFFFAOYSA-N 4-methyl-3-sulfanylpyrrolidin-2-one Chemical compound CC1CNC(=O)C1S HPZWRPBETAXFQZ-UHFFFAOYSA-N 0.000 description 1
- ATHBVBBZYRWNDC-UHFFFAOYSA-N 4-prop-2-enyl-3-sulfanyloxolan-2-one Chemical compound SC1C(CC=C)COC1=O ATHBVBBZYRWNDC-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- MJZNPHROJVAQAG-UHFFFAOYSA-N 5-ethyl-3-sulfanyloxan-2-one Chemical compound CCC1COC(=O)C(S)C1 MJZNPHROJVAQAG-UHFFFAOYSA-N 0.000 description 1
- ITMINNDBLGKHMN-UHFFFAOYSA-N 5-ethyl-3-sulfanylpiperidin-2-one Chemical compound CCC1CNC(=O)C(S)C1 ITMINNDBLGKHMN-UHFFFAOYSA-N 0.000 description 1
- XOQVFCUXIHLWBR-UHFFFAOYSA-N 5-ethyl-3-sulfanylpyrrolidin-2-one Chemical compound CCC1CC(S)C(=O)N1 XOQVFCUXIHLWBR-UHFFFAOYSA-N 0.000 description 1
- CDKATGNQOPXGRW-UHFFFAOYSA-N 5-methyl-3-sulfanylazepan-2-one Chemical compound CC1CCNC(=O)C(S)C1 CDKATGNQOPXGRW-UHFFFAOYSA-N 0.000 description 1
- VXCPBAMJKMXWOG-UHFFFAOYSA-N 5-methyl-3-sulfanyloxan-2-one Chemical compound CC1COC(=O)C(S)C1 VXCPBAMJKMXWOG-UHFFFAOYSA-N 0.000 description 1
- NMLXOVQLTMFJER-UHFFFAOYSA-N 5-methyl-3-sulfanyloxepan-2-one Chemical compound CC1CCOC(=O)C(S)C1 NMLXOVQLTMFJER-UHFFFAOYSA-N 0.000 description 1
- YRKZBSXWYWLZDS-UHFFFAOYSA-N 5-methyl-3-sulfanylpiperidin-2-one Chemical compound CC1CNC(=O)C(S)C1 YRKZBSXWYWLZDS-UHFFFAOYSA-N 0.000 description 1
- DEFHRYBJHWFRHC-UHFFFAOYSA-N 5-methyl-3-sulfanylpyrrolidin-2-one Chemical compound CC1CC(S)C(=O)N1 DEFHRYBJHWFRHC-UHFFFAOYSA-N 0.000 description 1
- RUOXUGUVTPTJBG-UHFFFAOYSA-N 6-ethyl-3-sulfanyloxan-2-one Chemical compound CCC1CCC(S)C(=O)O1 RUOXUGUVTPTJBG-UHFFFAOYSA-N 0.000 description 1
- KUESERFPJKQIGJ-UHFFFAOYSA-N 6-ethyl-3-sulfanylpiperidin-2-one Chemical compound CCC1CCC(S)C(=O)N1 KUESERFPJKQIGJ-UHFFFAOYSA-N 0.000 description 1
- MHVQIUFLJGGDOW-UHFFFAOYSA-N 6-methyl-3-sulfanylazepan-2-one Chemical compound CC1CCC(S)C(=O)NC1 MHVQIUFLJGGDOW-UHFFFAOYSA-N 0.000 description 1
- PSSHUGMXCPOHEF-UHFFFAOYSA-N 6-methyl-3-sulfanyloxan-2-one Chemical compound CC1CCC(S)C(=O)O1 PSSHUGMXCPOHEF-UHFFFAOYSA-N 0.000 description 1
- VRMFONOIIBUSTJ-UHFFFAOYSA-N 6-methyl-3-sulfanyloxepan-2-one Chemical compound CC1CCC(S)C(=O)OC1 VRMFONOIIBUSTJ-UHFFFAOYSA-N 0.000 description 1
- MZRCQIRMZFUSSQ-UHFFFAOYSA-N 6-methyl-3-sulfanylpiperidin-2-one Chemical compound CC1CCC(S)C(=O)N1 MZRCQIRMZFUSSQ-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- IDCARTFMHSNDFK-UHFFFAOYSA-N 7-methyl-3-sulfanylazepan-2-one Chemical compound CC1CCCC(S)C(=O)N1 IDCARTFMHSNDFK-UHFFFAOYSA-N 0.000 description 1
- VZJGNMLHULIKAE-UHFFFAOYSA-N 7-methyl-3-sulfanyloxepan-2-one Chemical compound CC1CCCC(S)C(=O)O1 VZJGNMLHULIKAE-UHFFFAOYSA-N 0.000 description 1
- BDDLHHRCDSJVKV-UHFFFAOYSA-N 7028-40-2 Chemical class CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O BDDLHHRCDSJVKV-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Chemical group OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- ROHFNLRQFUQHCH-RXMQYKEDSA-N D-leucine Chemical compound CC(C)C[C@@H](N)C(O)=O ROHFNLRQFUQHCH-RXMQYKEDSA-N 0.000 description 1
- 229930182819 D-leucine Natural products 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical class OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 206010016322 Feeling abnormal Diseases 0.000 description 1
- 239000004471 Glycine Chemical group 0.000 description 1
- 206010019049 Hair texture abnormal Diseases 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical group O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical group OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical group C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical group OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical group OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical group OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical group OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical group CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical group OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical group C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical group C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical group OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920001219 Polysorbate 40 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Chemical group OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Chemical group OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N Taurine Natural products NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Chemical group CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Chemical group 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Chemical group C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- NCHJGQKLPRTMAO-XWVZOOPGSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NCHJGQKLPRTMAO-XWVZOOPGSA-N 0.000 description 1
- PZQBWGFCGIRLBB-NJYHNNHUSA-N [(2r)-2-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-octadecanoyloxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1O PZQBWGFCGIRLBB-NJYHNNHUSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 125000005233 alkylalcohol group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- OPVLOHUACNWTQT-UHFFFAOYSA-N azane;2-dodecoxyethyl hydrogen sulfate Chemical compound N.CCCCCCCCCCCCOCCOS(O)(=O)=O OPVLOHUACNWTQT-UHFFFAOYSA-N 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- YSJGOMATDFSEED-UHFFFAOYSA-M behentrimonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C YSJGOMATDFSEED-UHFFFAOYSA-M 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- SXDBWCPKPHAZSM-UHFFFAOYSA-M bromate Chemical class [O-]Br(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-M 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- DDXLVDQZPFLQMZ-UHFFFAOYSA-M dodecyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)C DDXLVDQZPFLQMZ-UHFFFAOYSA-M 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Chemical group OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Chemical group OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229940014041 hyaluronate Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000003752 improving hair Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 229930182817 methionine Chemical group 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- NNSWOABHNWRKDR-UHFFFAOYSA-N n',n'-diethylethane-1,2-diamine;octadecanoic acid Chemical compound CCN(CC)CCN.CCCCCCCCCCCCCCCCCC(O)=O NNSWOABHNWRKDR-UHFFFAOYSA-N 0.000 description 1
- RVRFYZGKUZFYAH-UHFFFAOYSA-N n',n'-dimethylpropane-1,3-diamine;octadecanoic acid Chemical compound CN(C)CCCN.CCCCCCCCCCCCCCCCCC(O)=O RVRFYZGKUZFYAH-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- FATBGEAMYMYZAF-KTKRTIGZSA-N oleamide Chemical compound CCCCCCCC\C=C/CCCCCCCC(N)=O FATBGEAMYMYZAF-KTKRTIGZSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940056211 paraffin Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- FURYAADUZGZUGQ-UHFFFAOYSA-N phenoxybenzene;sulfuric acid Chemical class OS(O)(=O)=O.C=1C=CC=CC=1OC1=CC=CC=C1 FURYAADUZGZUGQ-UHFFFAOYSA-N 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Chemical group OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- YPPBDYVKAUMDML-UHFFFAOYSA-N prop-2-enamide;prop-2-enoic acid;hydrochloride Chemical compound Cl.NC(=O)C=C.OC(=O)C=C YPPBDYVKAUMDML-UHFFFAOYSA-N 0.000 description 1
- NPSSWQJHYLDCNV-UHFFFAOYSA-N prop-2-enoic acid;hydrochloride Chemical compound Cl.OC(=O)C=C NPSSWQJHYLDCNV-UHFFFAOYSA-N 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000037321 sleepiness Effects 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- HYHCSLBZRBJJCH-UHFFFAOYSA-M sodium hydrosulfide Chemical compound [Na+].[SH-] HYHCSLBZRBJJCH-UHFFFAOYSA-M 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 229960001922 sodium perborate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- YKLJGMBLPUQQOI-UHFFFAOYSA-M sodium;oxidooxy(oxo)borane Chemical compound [Na+].[O-]OB=O YKLJGMBLPUQQOI-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 229920001897 terpolymer Polymers 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- CWERGRDVMFNCDR-UHFFFAOYSA-M thioglycolate(1-) Chemical class [O-]C(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-M 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 125000005270 trialkylamine group Chemical group 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Chemical group OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Abstract
Description
本発明は、乳化した毛髪処理用薬剤、特にパーマネントウエーブ加工用薬剤に好適な毛髪処理用薬剤ならびにこれを用いる毛髪のパーマネントウエーブ加工方法に関する。 The present invention relates to a hair treatment agent suitable for an emulsified hair treatment agent, in particular, a permanent wave treatment agent, and a hair permanent wave processing method using the same.
パーマネントウエーブは2つの工程により形成されることが知られている。即ち、還元剤の作用により毛髪のシスチン(ジスルフィド)結合を還元切断する工程と、その後の酸化剤を使用した中和または固定工程であり、この後者の工程によりシスチン(ジスルフィド)結合が復元する。 It is known that a permanent wave is formed by two processes. That is, there are a step of reducing and cleaving the cystine (disulfide) bond of hair by the action of the reducing agent, and a subsequent neutralization or fixing step using an oxidizing agent, and the latter step restores the cystine (disulfide) bond.
従来、毛髪のパーマネント加工で使用される化合物は、チオグリコール酸、システイン、アセチルシステイン、およびこれらの塩類などの一般にケラチン還元物質ともいわれる化合物が使用されてきた。これらの従来のケラチン還元物質ともいわれる化合物は、毛髪のパーマネント加工用としてアルカリ性条件下で実用的な性能を有するため、多くのパーマ液はpH9.5程度のアルカリ性に調整されている。しかし、アルカリ性に調整されたパーマ液は、毛髪や頭皮の損傷を引き起こすことが知られており、これら不都合を解決するために中性から弱酸性のpH領域(pH:3〜7.5、25℃)で使用可能なケラチン還元物質の開発が進められている。 Conventionally, compounds generally used as keratin reducing substances such as thioglycolic acid, cysteine, acetylcysteine, and salts thereof have been used as compounds used in permanent processing of hair. Since these conventional compounds, which are also called keratin reducing substances, have practical performance under alkaline conditions for the permanent processing of hair, many permanent liquids are adjusted to be alkaline with a pH of about 9.5. However, it is known that perm liquid adjusted to alkaline causes damage to hair and scalp, and in order to solve these disadvantages, a neutral to slightly acidic pH range (pH: 3 to 7.5, 25). The development of keratin reducing substances that can be used at 0 ° C is underway.
例えば、このようなpH領域で使用されるケラチン還元物質として、チオグリコール酸のモノグリセロールエステルの使用が検討されている(例えば、特許文献1)。また、チオグリコール酸エステルでみられる皮膚障害を解決する目的でメルカプトグリコール酸アミド誘導体およびメルカプト乳酸アミド誘導体の使用も検討されている(例えば、特許文献2、特許文献3)。さらには、弱酸性で効果を発揮するとされるシステアミンの使用も検討されている。(例えば、特許文献4)
しかしながら、特許文献1に提案されたチオグリコール酸モノグリセロールエステルは液状であり、取り扱い性、臭気に関しては優れているが、その構造中の水酸基に由来すると推定される感作性の報告もあり実用には至っていない。 However, the thioglycolic acid monoglycerol ester proposed in Patent Document 1 is in a liquid state and is excellent in terms of handleability and odor, but there is also a report of sensitization presumed to be derived from a hydroxyl group in the structure. It has not reached.
特許文献2に提案されたメルカプトカルボン酸アミドには、皮膚刺激性があることは既に知られており、また特許文献3に提案されたメルカプトカルボン酸アミド誘導体でも同様の感作性が懸念され、更には精製不足や保存中に遊離する原料アミンによる感作性、皮膚刺激性なども懸念されるという問題がある。 The mercaptocarboxylic acid amide proposed in Patent Document 2 is already known to have skin irritation, and the same sensitization is also a concern with the mercaptocarboxylic acid amide derivative proposed in Patent Document 3, Furthermore, there is a problem that there is a concern about lack of purification, sensitization by raw material amine released during storage, and skin irritation.
特許文献4に提案されたシステアミンは、弱酸性〜酸性でのウエーブ性能は十分ではなく、更には、パーマ処置後の頭髪が独特の臭気を有するなど課題が多い。
このように従来より提案されていたケラチン還元物質では、必ずしも所望のパーマネントウエーブ加工用薬剤は得られていないのが現状であった。
The cysteamine proposed in Patent Document 4 does not have sufficient wave performance from weak acidity to acidity, and there are many problems such as the hair after perm treatment has a unique odor.
As described above, in the conventional keratin reducing substances, the desired permanent wave processing chemicals have not always been obtained.
かかる問題を解決するものとして、本出願人は既に、式(1)等で示される環状メルカ
プト化合物をケラチン還元性物質として含むパーマネントウエーブ加工用薬剤を提案した。このパーマネントウエーブ加工用薬剤によれば、毛髪や皮膚への刺激が少ない中性から弱酸性のpH領域において、既知の化合物よりも高いウエーブ性能を有し、毛髪や皮膚に与える刺激を軽減しつつ毛髪に確実にウエーブ加工を施すことができる。
As a solution to this problem, the present applicant has already proposed a permanent wave processing agent containing a cyclic mercapto compound represented by the formula (1) or the like as a keratin-reducing substance. This permanent waving agent has higher wave performance than known compounds in a neutral to weakly acidic pH range where there is little irritation to hair and skin, while reducing irritation to hair and skin. Wave processing can be reliably applied to the hair.
しかしながら、該環状メルカプト化合物の水溶液中での安定性は充分とはいえず、改善の余地があった。すなわち、この特定の環状メルカプト化合物は、水溶液中では経時的に分解してしまうため、パーマネントウエーブ加工用薬剤が水を含む場合には、薬剤中の環状メルカプト化合物濃度が経時的に減少する上、分解に伴い着色や沈殿などが生じて外観を損ない商品価値を低下させるという問題点がある。 However, the stability of the cyclic mercapto compound in an aqueous solution is not sufficient, and there is room for improvement. That is, since this specific cyclic mercapto compound decomposes with time in an aqueous solution, when the permanent waving agent contains water, the concentration of the cyclic mercapto compound in the agent decreases with time. There is a problem that coloring, precipitation, and the like occur along with the decomposition, deteriorating the appearance and reducing the commercial value.
このため、本発明は、水を含む薬剤中での上記環状メルカプト化合物の安定性を向上させ、薬剤中の環状メルカプト化合物濃度の経時的な減少、薬剤の着色や沈殿発生などを防止し、長期にわたって安定な性能と優れた外観とを有する毛髪処理用薬剤を提供することを目的とする。 For this reason, the present invention improves the stability of the cyclic mercapto compound in a drug containing water, prevents the cyclic mercapto compound concentration in the drug from decreasing over time, prevents the coloring or precipitation of the drug, and the like. An object of the present invention is to provide a hair treatment agent having a stable performance and an excellent appearance.
本発明者らは、鋭意研究を重ねた結果、特定の環状メルカプト化合物と界面活性剤と水とを含有してなり、乳化した毛髪処理用薬剤によれば、薬剤中の該環状メルカプト化合物の安定性を向上させることができることを見出し、本発明を完成するに至った。 As a result of intensive research, the inventors of the present invention contain a specific cyclic mercapto compound, a surfactant, and water, and according to the emulsified hair treatment agent, the stability of the cyclic mercapto compound in the agent is stable. The inventors have found that the properties can be improved, and have completed the present invention.
すなわち、本発明は、たとえば、以下の(1)〜(15)の事項を含む。
(1)下記式(1)で示される化合物と界面活性剤と水とを含有し、乳化していることを特徴とする毛髪処理用薬剤;
That is, the present invention includes the following items (1) to (15), for example.
(1) A hair treatment agent comprising a compound represented by the following formula (1), a surfactant, and water and emulsifying;
(Xは−O−、−S−、−NH−、−NR1−のいずれかの構造を示す。R1は炭素数1〜6のアルキル基を示す。R2は水素原子または炭素数1〜6のアルキル基を示す。Yは酸
素原子または硫黄原子を示す。Rはメルカプト基を有してもよい二価の有機残基を示す。)。
(X represents a structure of any of —O—, —S—, —NH—, and —NR 1 —. R 1 represents an alkyl group having 1 to 6 carbon atoms. R 2 represents a hydrogen atom or 1 carbon atom. Represents an alkyl group of ˜6, Y represents an oxygen atom or a sulfur atom, and R represents a divalent organic residue which may have a mercapto group.
(2)前記式(1)のXが、−O−、−NH−、−NCH3−または−S−であること
を特徴とする上記(1)に記載の毛髪処理用薬剤。
(3)前記式(1)のYが、酸素原子であることを特徴とする上記(1)または(2)に記載の毛髪処理用薬剤。
X (2) Formula (1) is, -O -, - NH -, - NCH 3 - , or -S- hair treatment agent according to (1), characterized in that.
(3) The hair treatment agent according to (1) or (2) above, wherein Y in the formula (1) is an oxygen atom.
(4)前記式(1)のRが、アルキレン基であることを特徴とする上記(1)〜(3)のいずれかに記載の毛髪処理用薬剤。
(5)前記式(1)のRが、一つ以上のメルカプト基を有するアルキレン基であることを特徴とする上記(1)〜(3)のいずれかに記載のパーマネントウエーブ加工用薬剤。
(4) The hair treatment agent according to any one of the above (1) to (3), wherein R in the formula (1) is an alkylene group.
(5) The permanent waving agent according to any one of (1) to (3) above, wherein R in the formula (1) is an alkylene group having one or more mercapto groups.
(6)前記式(1)で示される化合物が、2−メルカプト−4−ブチロラクトン、2−メルカプト−4−メチル−4−ブチロラクトン、2−メルカプト−4−エチル−4−ブチロラクトンおよび2−メルカプト−6−ヘキサノラクタムからなる群から選ばれる少なくとも1種であることを特徴とする上記(1)に記載の毛髪処理用薬剤。 (6) The compound represented by the formula (1) is 2-mercapto-4-butyrolactone, 2-mercapto-4-methyl-4-butyrolactone, 2-mercapto-4-ethyl-4-butyrolactone and 2-mercapto- The hair treatment agent according to (1) above, which is at least one selected from the group consisting of 6-hexanolactam.
(7)前記界面活性剤が、非イオン性界面活性剤、陽イオン性界面活性剤、陰イオン性界面活性剤、両性界面活性剤、高分子界面活性剤、バイオサーファクタントからなる群から選ばれる少なくとも1種であることを特徴とする上記(1)〜(6)のいずれかに記載の毛髪処理用薬剤。 (7) The surfactant is at least selected from the group consisting of a nonionic surfactant, a cationic surfactant, an anionic surfactant, an amphoteric surfactant, a polymer surfactant, and a biosurfactant. The hair treatment agent according to any one of the above (1) to (6), wherein the hair treatment agent is one type.
(8)前記非イオン性界面活性剤が、ポリオキシエチレン付加モル数10〜100の、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンアルケニルエーテル、ポリオキシエチレンアルキルフェニルエーテルからなる群から選ばれる少なくとも1種であることを特徴とする上記(7)に記載の毛髪処理用薬剤。 (8) The nonionic surfactant is at least one selected from the group consisting of polyoxyethylene alkyl ether, polyoxyethylene alkenyl ether, polyoxyethylene alkylphenyl ether having 10 to 100 polyoxyethylene addition moles. The hair treatment agent according to (7) above, wherein
(9)前記非イオン性界面活性剤が、シリコーン系非イオン性界面活性剤であることを特徴とする上記(7)に記載の毛髪処理用薬剤。
(10)前記バイオサーファクタントが、リポペプチド構造を有することを特徴とする上記(7)に記載の毛髪処理用薬剤。
(9) The hair treatment agent according to (7) above, wherein the nonionic surfactant is a silicone-based nonionic surfactant.
(10) The hair treatment agent according to (7), wherein the biosurfactant has a lipopeptide structure.
(11)前記式(1)で示される化合物が、還元物質の含有率(チオグリコール酸として)で、0.2〜30%の量で含まれていることを特徴とする上記(1)〜(10)のいずれかに記載の毛髪処理用薬剤。 (11) The compound represented by the formula (1) is contained in an amount of 0.2 to 30% as a reducing substance content (as thioglycolic acid). (10) The hair treatment agent according to any one of (10).
(12)前記界面活性剤が、0.1〜10質量%の量で含まれていることを特徴とする上記(1)〜(11)のいずれかに記載の毛髪処理用薬剤。
(13)薬剤のpHが4.0〜7.5であることを特徴とする上記(1)〜(12)のいずれかに記載の毛髪処理用薬剤。
(12) The hair treatment agent according to any one of (1) to (11) above, wherein the surfactant is contained in an amount of 0.1 to 10% by mass.
(13) The hair treatment agent according to any one of (1) to (12) above, wherein the pH of the agent is 4.0 to 7.5.
(14)パーマネントウエーブ加工用薬剤であることを特徴とする上記(1)〜(13)のいずれかに記載の毛髪処理剤。
(15)上記(1)〜(13)のいずれかに記載の毛髪処理用薬剤をパーマネントウエーブ加工用薬剤として用いることを特徴とする毛髪のパーマネントウエーブ加工方法。
(14) The hair treatment agent according to any one of (1) to (13) above, which is a permanent wave processing agent.
(15) A permanent wave processing method for hair, wherein the hair treatment agent according to any one of (1) to (13) is used as a permanent wave processing agent.
本発明の毛髪処理用薬剤によれば、水の存在下であっても、特定の環状メルカプト化合物の薬剤中での安定性を向上させ、薬剤中の環状メルカプト化合物濃度の経時的な減少、薬剤の着色や沈殿発生などを防止し、長期にわたって安定な性能と優れた外観とを維持することができる。 According to the hair treatment drug of the present invention, even in the presence of water, the stability of a specific cyclic mercapto compound in the drug is improved, and the concentration of the cyclic mercapto compound in the drug is reduced over time. Coloring and precipitation can be prevented, and stable performance and excellent appearance can be maintained over a long period of time.
すなわち、本発明の毛髪処理用薬剤をパーマネントウエーブ加工用薬剤として用いた場合には、中性から弱酸性のpH領域における優れたパーマネント加工性能を長期保存後も変わらずに発揮することができる上、変色や沈殿発生などの外観不良を抑え、商品価値をより一層高めることができる。 That is, when the hair treatment agent of the present invention is used as a permanent wave processing agent, excellent permanent processing performance in a neutral to weakly acidic pH region can be exhibited without change even after long-term storage. In addition, appearance defects such as discoloration and precipitation can be suppressed, and the commercial value can be further increased.
したがって、本発明の毛髪処理用薬剤はパーマネントウエーブ加工用薬剤として好適であり、毛髪のパーマネント加工に極めて有用である。 Therefore, the hair treatment agent of the present invention is suitable as a permanent wave processing agent, and is extremely useful for permanent processing of hair.
以下、本発明について具体的に説明する。
本発明の毛髪処理用薬剤は下記式(1)で示される化合物と界面活性剤と水とを含有し、乳化していることを特徴としている。
Hereinafter, the present invention will be specifically described.
The hair treatment agent of the present invention contains a compound represented by the following formula (1), a surfactant and water and is emulsified.
環状メルカプト化合物
本発明の毛髪処理用薬剤には、少なくとも下記式(1)で示される環状メルカプト化合物が含まれている。
Cyclic Mercapto Compound The hair treatment agent of the present invention contains at least a cyclic mercapto compound represented by the following formula (1).
上記式(1)中、Xは−O−、−S−、−NH−、−NR1−のいずれかの構造を示し
、R1は炭素数1〜6のアルキル基を示す。R2は水素原子または炭素数1〜6のアルキル基を示す。Yは酸素原子または硫黄原子を示す。Rはメルカプト基を有してもよい二価の有機残基を示す。
In the above formula (1), X is -O -, - S -, - NH -, - NR 1 - shows the structure of any of, R 1 represents an alkyl group having 1 to 6 carbon atoms. R 2 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms. Y represents an oxygen atom or a sulfur atom. R represents a divalent organic residue which may have a mercapto group.
R1としては、メチル基、エチル基が毛髪への浸透性向上の点で望ましい。さらに好ま
しくは、R1がメチル基である。
Xとしては、−O−、−NH−、−NCH3−または−S−であることが、水溶液とし
て使用されることの多い毛髪処理用薬剤の調製の際に水溶液への溶解度が比較的高く、液調製の点で好ましい。
As R 1 , a methyl group and an ethyl group are desirable from the viewpoint of improving the permeability to hair. More preferably, R 1 is a methyl group.
X is —O—, —NH—, —NCH 3 — or —S—, which has a relatively high solubility in an aqueous solution when preparing a hair treatment agent often used as an aqueous solution. From the viewpoint of liquid preparation.
式(1)において、Yは酸素原子または硫黄原子を示すが、酸素原子が工業的な原料入手や取り扱い性の点でより好ましい。
また、R2としては、水素原子、メチル基、エチル基、プロピル基などが例示され、な
かでも水素原子、メチル基、エチル基が好適である。
In the formula (1), Y represents an oxygen atom or a sulfur atom, and an oxygen atom is more preferable from the viewpoint of industrial raw material availability and handleability.
Examples of R 2 include a hydrogen atom, a methyl group, an ethyl group, and a propyl group. Among them, a hydrogen atom, a methyl group, and an ethyl group are preferable.
Rはメルカプト基(−SH)を有してもよい二価の有機残基を示す。Rは、二価の有機基であれば、特に限定されないが、アルキレン基が好ましい。アルキレン基としては、主鎖の炭素数が2〜6のアルキレン基が好ましい。また、分岐および/または側鎖を有して
いてもよい。側鎖としては、アルキル基、アルケニル基などが挙げられる。
R represents a divalent organic residue which may have a mercapto group (-SH). R is not particularly limited as long as it is a divalent organic group, but is preferably an alkylene group. As the alkylene group, an alkylene group having 2 to 6 carbon atoms in the main chain is preferable. Moreover, you may have a branch and / or a side chain. Examples of the side chain include an alkyl group and an alkenyl group.
また、Rがメルカプト基を有する場合、当該メルカプト基は1つであっても複数個であっても良いが、1個または2個が好ましい。とくに二価の有機残基としてはアルキレン基にメルカプト基が結合しているものが好ましい。また、アルキレン基へメルカプト基が結合する位置に特に制限はない。メルカプト基は直接アルキレン基に結合していても、さらにアルキレン基などを介していてもよい(例えばメルカプトエチル基)。 Moreover, when R has a mercapto group, the mercapto group may be one or plural, but one or two is preferable. In particular, the divalent organic residue is preferably one having a mercapto group bonded to an alkylene group. Moreover, there is no restriction | limiting in particular in the position which a mercapto group couple | bonds with an alkylene group. The mercapto group may be directly bonded to the alkylene group, or may be further via an alkylene group (for example, a mercaptoethyl group).
中でも、好ましいRとしては、工業的入手のしやすさの点でエチレン基、プロピレン基が挙げられる。
式(1)で示される化合物の具体例としては、2−メルカプト−3−プロピオラクトン、2−メルカプト−2−メチル−3−プロピオラクトン、2−メルカプト−3−メチル−
3−プロピオラクトン、2−メルカプト−3−エチル−3−プロピオラクトン、2−メルカプト−2,3−ジメチル−3−プロピオラクトン、2−メルカプト−3−プロピオラクタム、2−メルカプト−2−メチル−3−プロピオラクタム、2−メルカプト−3−メチル−3−プロピオラクタム、2−メルカプト−3−エチル−3−プロピオラクタム、2−メルカプト−2,3−ジメチル−3−プロピオラクタム、2−メルカプト−3−プロピオチオラクトン、2−メルカプト−2−メチル−3−プロピオチオラクトン、2−メルカプト−3−メチル−3−プロピオチオラクトン、2−メルカプト−3−エチル−3−プロピオチオラクトン、2−メルカプト−2,3−ジメチル−3−プロピオチオラクトン、2−メルカプト−4−ブチロラクトン、2−メルカプト−2−メチル−4,4−ジメチル−4−ブチロラクトン、2−メルカプト−3−(2−プロペニル)−4−ブチロラクトン、2−メルカプト−4−メチル−4−ブチロラクトン、2−メルカプト−2−メチル−4−ブチロラクトン、2−メルカプト−3−メチル−4−ブチロラクトン、2−メルカプト−4−メチル−4−ブチロラクトン、2−メルカプト−3,4−ジメチル−4−ブチロラクトン、2−メルカプト−2−エチル−4−ブチロラクトン、2−メルカプト−3−エチル−4−ブチロラクトン、2−メルカプト−4−エチル−4−ブチロラクトン、2−メルカプト−4−ブチロチオラクトン、2−メルカプト−2−メチル−4−ブチロチオラクトン、
Among these, preferable R includes an ethylene group and a propylene group in terms of industrial availability.
Specific examples of the compound represented by the formula (1) include 2-mercapto-3-propiolactone, 2-mercapto-2-methyl-3-propiolactone, 2-mercapto-3-methyl-
3-propiolactone, 2-mercapto-3-ethyl-3-propiolactone, 2-mercapto-2,3-dimethyl-3-propiolactone, 2-mercapto-3-propiolactam, 2-mercapto- 2-Methyl-3-propiolactam, 2-mercapto-3-methyl-3-propiolactam, 2-mercapto-3-ethyl-3-propiolactam, 2-mercapto-2,3-dimethyl-3- Propiolactam, 2-mercapto-3-propiothiolactone, 2-mercapto-2-methyl-3-propiothiolactone, 2-mercapto-3-methyl-3-propiothiolactone, 2-mercapto-3 -Ethyl-3-propiothiolactone, 2-mercapto-2,3-dimethyl-3-propiothiolactone, 2-mercapto-4-butyrolac 2-mercapto-2-methyl-4,4-dimethyl-4-butyrolactone, 2-mercapto-3- (2-propenyl) -4-butyrolactone, 2-mercapto-4-methyl-4-butyrolactone, 2- Mercapto-2-methyl-4-butyrolactone, 2-mercapto-3-methyl-4-butyrolactone, 2-mercapto-4-methyl-4-butyrolactone, 2-mercapto-3,4-dimethyl-4-butyrolactone, 2- Mercapto-2-ethyl-4-butyrolactone, 2-mercapto-3-ethyl-4-butyrolactone, 2-mercapto-4-ethyl-4-butyrolactone, 2-mercapto-4-butyrothiolactone, 2-mercapto-2 -Methyl-4-butyrothiolactone,
2−メルカプト−3−メチル−4−ブチロチオラクトン、2−メルカプト−4−メチル−4−ブチロチオラクトン、2−メルカプト−3,4−ジメチル−4−ブチロチオラクトン、2−メルカプト−2−エチル−4−ブチロチオラクトン、2−メルカプト−3−エチル−4−ブチロチオラクトン、2−メルカプト−4−エチル−4−ブチロチオラクトン、2−メルカプト−4−ブチロラクタム、2−メルカプト−2−メチル−4−ブチロラクタム、2−メルカプト−3−メチル−4−ブチロラクタム、2−メルカプト−4−メチル−4−ブチロラクタム、2−メルカプト−3,4−ジメチル−4−ブチロラクタム、2−メルカプト−2−エチル−4−ブチロラクタム、2−メルカプト−3−エチル−4−ブチロラクタム、2−メルカプト−4−エチル−4−ブチロラクタム、2−メルカプト−5−バレロラクトン、2−メルカプト−2−メチル−5−バレロラクトン、2−メルカプト−3−メチル−5−バレロラクトン、2−メルカプト−4−メチル−5−バレロラクトン、2−メルカプト−5−メチル−5−バレロラクトン、2−メルカプト−2−エチル−5−バレロラクトン、2−メルカプト−3−エチル−5−バレロラクトン、2−メルカプト−4−エチル−5−バレロラクトン、2−メルカプト−5−エチル−5−バレロラクトン、2−メルカプト−5−バレロラクタム、2−メルカプト−2−メチル−5−バレロラクタム、 2-mercapto-3-methyl-4-butyrothiolactone, 2-mercapto-4-methyl-4-butyrothiolactone, 2-mercapto-3,4-dimethyl-4-butyrothiolactone, 2-mercapto 2-ethyl-4-butyrothiolactone, 2-mercapto-3-ethyl-4-butyrothiolactone, 2-mercapto-4-ethyl-4-butyrothiolactone, 2-mercapto-4-butyrolactam, 2-mercapto-2-methyl-4-butyrolactam, 2-mercapto-3-methyl-4-butyrolactam, 2-mercapto-4-methyl-4-butyrolactam, 2-mercapto-3,4-dimethyl-4-butyrolactam, 2-mercapto-2-ethyl-4-butyrolactam, 2-mercapto-3-ethyl-4-butyrolactam, 2-mercapto-4 Ethyl-4-butyrolactam, 2-mercapto-5-valerolactone, 2-mercapto-2-methyl-5-valerolactone, 2-mercapto-3-methyl-5-valerolactone, 2-mercapto-4-methyl-5 -Valerolactone, 2-mercapto-5-methyl-5-valerolactone, 2-mercapto-2-ethyl-5-valerolactone, 2-mercapto-3-ethyl-5-valerolactone, 2-mercapto-4-ethyl -5-valerolactone, 2-mercapto-5-ethyl-5-valerolactone, 2-mercapto-5-valerolactam, 2-mercapto-2-methyl-5-valerolactam,
2−メルカプト−3−メチル−5−バレロラクタム、2−メルカプト−4−メチル−5−バレロラクタム、2−メルカプト−5−メチル−5−バレロラクタム、2−メルカプト−2−エチル−5−バレロラクタム、2−メルカプト−3−エチル−5−バレロラクタム、2−メルカプト−4−エチル−5−バレロラクタム、2−メルカプト−5−エチル−5−バレロラクタム、2−メルカプト−5−バレロチオラクトン、2−メルカプト−2−メチル−5−バレロチオラクトン、2−メルカプト−3−メチル−5−バレロチオラクトン、2−メルカプト−4−メチル−5−バレロチオラクトン、2−メルカプト−5−メチル−5−バレロチオラクトン、2−メルカプト−2−エチル−5−バレロチオラクトン、2−メルカプト−3−エチル−5−バレロチオラクトン、2−メルカプト−4−エチル−5−バレロチオラクトン、2−メルカプト−5−エチル−5−バレロチオラクトン、2−メルカプト−6−ヘキサノラクトン、2−メルカプト−2−メチル−6−ヘキサノラクトン、
2-mercapto-3-methyl-5-valerolactam, 2-mercapto-4-methyl-5-valerolactam, 2-mercapto-5-methyl-5-valerolactam, 2-mercapto-2-ethyl-5-valero Lactam, 2-mercapto-3-ethyl-5-valerolactam, 2-mercapto-4-ethyl-5-valerolactam, 2-mercapto-5-ethyl-5-valerolactam, 2-mercapto-5-valerothiolactone 2-mercapto-2-methyl-5-valerothiolactone, 2-mercapto-3-methyl-5-valerothiolactone, 2-mercapto-4-methyl-5-valerothiolactone, 2-mercapto-5-methyl -5-valerothiolactone, 2-mercapto-2-ethyl-5-valerothiolactone, 2-mercapto-3-ethyl-5 Valerothiolactone, 2-mercapto-4-ethyl-5-valerothiolactone, 2-mercapto-5-ethyl-5-valerothiolactone, 2-mercapto-6-hexanolactone, 2-mercapto-2-methyl- 6-hexanolactone,
2−メルカプト−3−メチル−6−ヘキサノラクトン、2−メルカプト−4−メチル−6−ヘキサノラクトン、2−メルカプト−5−メチル−6−ヘキサノラクトン、2−メルカプト−6−メチル−6−ヘキサノラクトン、2−メルカプト−6−ヘキサノラクタム、2−メルカプト−2−メチル−6−ヘキサノラクタム、2−メルカプト−3−メチル−6−
ヘキサノラクタム、2−メルカプト−4−メチル−6−ヘキサノラクタム、2−メルカプト−5−メチル−6−ヘキサノラクタム、2−メルカプト−6−メチル−6−ヘキサノラクタム、2−メルカプト−6−ヘキサノチオラクトン、2−メルカプト−2−メチル−6−ヘキサノチオラクトン、2−メルカプト−3−メチル−6−ヘキサノチオラクトン、2−メルカプト−4−メチル−6−ヘキサノチオラクトン、2−メルカプト−5−メチル−6−ヘキサノチオラクトン、2−メルカプト−6−メチル−6−ヘキサノチオラクトン、2−メルカプト−7−ヘプタノラクトン、2−メルカプト−7−ヘプタノチオラクトン、2−メルカプト−7−ヘプタノラクタム、2−メルカプト−8−オクタノラクトン、2−メルカプト−8−オクタノチオラクトン、2−メルカプト−8−オクタノラクタム、2−メルカプト−9−ノナラクトン、2−メルカプト−9−ノナチオラクトン、2−メルカプト−9−ノナラクタム、および、これらラクタム類のN−メチルあるいはN−エチル誘導体などが挙げられる。
2-mercapto-3-methyl-6-hexanolactone, 2-mercapto-4-methyl-6-hexanolactone, 2-mercapto-5-methyl-6-hexanolactone, 2-mercapto-6-methyl- 6-hexanolactone, 2-mercapto-6-hexanolactam, 2-mercapto-2-methyl-6-hexanolactam, 2-mercapto-3-methyl-6
Hexanolactam, 2-mercapto-4-methyl-6-hexanolactam, 2-mercapto-5-methyl-6-hexanolactam, 2-mercapto-6-methyl-6-hexanolactam, 2-mercapto- 6-hexanothiolactone, 2-mercapto-2-methyl-6-hexanothiolactone, 2-mercapto-3-methyl-6-hexanothiolactone, 2-mercapto-4-methyl-6-hexanothiolactone, 2- Mercapto-5-methyl-6-hexanothiolactone, 2-mercapto-6-methyl-6-hexanothiolactone, 2-mercapto-7-heptanolactone, 2-mercapto-7-heptanothiolactone, 2-mercapto- 7-heptanolactam, 2-mercapto-8-octanolactone, 2-mercapto-8-octanochi Lactone, 2-mercapto-8-octanolactam, 2-mercapto-9-nonalactone, 2-mercapto-9-nonathiolactone, 2-mercapto-9-nonalactam, and N-methyl or N- of these lactams Examples thereof include ethyl derivatives.
これらの中でも、2−メルカプト−4−ブチロラクトン(2−メルカプト−4−ブタノリド)、2−メルカプト−4−ブチロチオラクトン、2−メルカプト−4−ブチロラクタム、2−メルカプト−4−メチル−4−ブチロラクトン、2−メルカプト−4−エチル−4−ブチロラクトン、2−メルカプト−5−バレロラクトン、2−メルカプト−5−バレロラクタム、2−メルカプト−6−ヘキサノラクタムが、パーマ性能、毛髪のくせ毛直し、カール伸ばしなどの毛髪矯正性能および工業的な製造の観点で好ましい。 Among these, 2-mercapto-4-butyrolactone (2-mercapto-4-butanolide), 2-mercapto-4-butyrothiolactone, 2-mercapto-4-butyrolactam, 2-mercapto-4-methyl-4- Butyrolactone, 2-mercapto-4-ethyl-4-butyrolactone, 2-mercapto-5-valerolactone, 2-mercapto-5-valerolactam, 2-mercapto-6-hexanolactam have permanent performance, hair straightening From the viewpoint of hair straightening performance such as curling and industrial production.
これらの化合物は、既知の方法に準じて製造可能である。例えば、ラクトン化合物、ラクタム化合物をハロゲン化化合物としたのちにメルカプト基を導入することで合成できる。 These compounds can be produced according to known methods. For example, it can be synthesized by introducing a mercapto group after using a lactone compound or a lactam compound as a halogenated compound.
具体的には、メルカプトラクトン及びメルカプトチオラクトンは、市販のラクトンあるいはチオラクトンを使用して、J.Am.Chem.Soc.1945,.67.2218−2220に記載された方法により合成したハロゲン体、あるいは市販で入手可能なハロゲン体を用いて、さらにAnn.1960,639.146−56に記載された方法に準じて反応させることでラクトン誘導体が合成できる。 Specifically, mercaptolactone and mercaptothiolactone are commercially available using a commercially available lactone or thiolactone. Am. Chem. Soc. 1945,. 67. 2218-2220, a halogen compound synthesized by the method described in 67.2218-2220, or a commercially available halogen compound, is further used in Ann. A lactone derivative can be synthesized by reacting according to the method described in 1960, 639.146-56.
メルカプトラクタム類は、J.Am.Chem.Soc.1958.80.6233−6237に記載された方法に準じて合成したハロゲン化合物を用いて、ラクトン類と同様にAnn.1960,639.146−56に記載された方法に準じて反応させることによりラクタム誘導体を合成できる。 Mercaplactams are described in J. Org. Am. Chem. Soc. 1958.80.6233-6237, using a halogen compound synthesized according to the method described in Ann. A lactam derivative can be synthesized by reacting according to the method described in 1960, 639.146-56.
このようなメルカプト化合物を、毛髪処理用薬剤の主成分として使用すると、毛髪に影響を与えない低pHで作用するとともに、良好なパーマネントウエーブ効果を発揮し、また、毛髪のくせ毛直し、カール伸ばしなどにも効果を発揮し、皮膚に対する影響も少ない。その理由は明確ではないものの、前記化合物の構造を有することで従来の還元剤よりも親油性が増し、毛髪への浸透性が向上すると共に、複素環を有していることによってメルカプト化合物が酸化されやすく、特に、中性、弱酸性でより酸化されやすく、その結果、従来より使用されていたメルカプト化合物と異なり、アルカリ性にせずとも還元剤として機能を発揮すると思料される。 When such a mercapto compound is used as the main component of a hair treatment agent, it acts at a low pH that does not affect the hair, and exhibits a good permanent wave effect. Is also effective and has little effect on the skin. Although the reason for this is not clear, having the structure of the compound increases lipophilicity compared to conventional reducing agents, improves hair permeability, and has a heterocyclic ring to oxidize mercapto compounds. In particular, it is likely to be neutral and weakly acidic and more easily oxidized. As a result, unlike mercapto compounds that have been used conventionally, it is considered that they function as a reducing agent without being alkaline.
ただし、このようなメルカプト化合物は、水との共存下では経時によって分解反応が生じやすい。
界面活性剤、水
本発明の毛髪処理用薬剤には、上記環状メルカプト化合物のほかに、界面活性剤および水が含まれている。本発明では、上記環状メルカプト化合物に加えて、界面活性剤を含むため、水の存在下において上記環状メルカプト化合物を乳化した状態で安定に保つことが
できる。
However, such a mercapto compound tends to undergo a decomposition reaction over time in the presence of water.
Surfactants, the hair processing agents of the water present invention, in addition to the above cyclic mercapto compound includes a surfactant and water. In the present invention, since the surfactant is contained in addition to the cyclic mercapto compound, the cyclic mercapto compound can be stably maintained in an emulsified state in the presence of water.
本発明の毛髪処理用薬剤に用いることのできる界面活性剤としては、水の存在下で上記環状メルカプト化合物を充分に乳化できるものであればよく、とくに限定されないが、非イオン性界面活性剤、陽イオン性界面活性剤、陰イオン性界面活性剤、両性界面活性剤、高分子界面活性剤、バイオサーファクタントからなる群から選ばれる少なくとも1種が好ましく挙げられる。 The surfactant that can be used for the hair treatment agent of the present invention is not particularly limited as long as it can sufficiently emulsify the cyclic mercapto compound in the presence of water. Preferable examples include at least one selected from the group consisting of a cationic surfactant, an anionic surfactant, an amphoteric surfactant, a polymer surfactant, and a biosurfactant.
非イオン性界面活性剤としては、
ポリオキシエチレン(2)ラウリルエーテル、ポリオキシエチレン(4.2)ラウリルエーテル、ポリオキシエチレン(9)ラウリルエーテル、ポリオキシエチレン(21)ラウリルエーテル、ポリオキシエチレン(23)ラウリルエーテル、ポリオキシエチレン(25)ラウリルエーテル、ポリオキシエチレン(2)セチルエーテル、ポリオキシエチレン(5,5)セチルエーテル、ポリオキシエチレン(7)セチルエーテル、ポリオキシエチレン(10)セチルエーテル、ポリオキシエチレン(15)セチルエーテル、ポリオキシエチレン(20)セチルエーテル、ポリオキシエチレン(23)セチルエーテル、ポリオキシエチレン(25)セチルエーテル、ポリオキシエチレン(30)セチルエーテル、ポリオキシエチレン(40)セチルエーテル、ポリオキシエチレン(2)ステアリルエーテル、ポリオキシエチレン(4)ステアリルエーテル、ポリオキシエチレン(20)ステアリルエーテル、ポリオキシエチレン(5)ベヘニルエーテル、ポリオキシエチレン(10)ベヘニルエーテル、ポリオキシエチレン(20)ベヘニルエーテル、ポリオキシエチレン(30)ベヘニルエーテル、ポリオキシエチレン(2)アルキルエーテル、ポリオキシエチレン(4)アルキルエーテル、ポリオキシエチレン(10)アルキルエーテルなどのポリオキシエチレンアルキルエーテル;
ポリオキシエチレン(16)ノニルフェニルエーテルなどのポリオキシエチレンアルキルフェニルエーテル;
Non-ionic surfactants include
Polyoxyethylene (2) lauryl ether, polyoxyethylene (4.2) lauryl ether, polyoxyethylene (9) lauryl ether, polyoxyethylene (21) lauryl ether, polyoxyethylene (23) lauryl ether, polyoxyethylene (25) Lauryl ether, polyoxyethylene (2) cetyl ether, polyoxyethylene (5,5) cetyl ether, polyoxyethylene (7) cetyl ether, polyoxyethylene (10) cetyl ether, polyoxyethylene (15) Cetyl ether, polyoxyethylene (20) cetyl ether, polyoxyethylene (23) cetyl ether, polyoxyethylene (25) cetyl ether, polyoxyethylene (30) cetyl ether, polyoxyethylene (40) Ether, polyoxyethylene (2) stearyl ether, polyoxyethylene (4) stearyl ether, polyoxyethylene (20) stearyl ether, polyoxyethylene (5) behenyl ether, polyoxyethylene (10) behenyl ether, polyoxyethylene (20) polyoxyethylene alkyl ethers such as behenyl ether, polyoxyethylene (30) behenyl ether, polyoxyethylene (2) alkyl ether, polyoxyethylene (4) alkyl ether, polyoxyethylene (10) alkyl ether;
Polyoxyethylene alkylphenyl ethers such as polyoxyethylene (16) nonylphenyl ether;
ポリオキシエチレン(7)オレイルエーテル、ポリオキシエチレン(10)オレイルエーテル、ポリオキシエチレン(15)オレイルエーテル、ポリオキシエチレン(20)オレイルエーテル、ポリオキシエチレン(50)オレイルエーテルなどのポリオキシエチレンアルケニルエーテル;
ポリオキシエチレン(1)ポリオキシプロピレン(4)セチルエーテル、ポリオキシエチレン(10)ポリオキシプロピレン(4)セチルエーテル、ポリオキシエチレン(1)ポリオキシプロピレン(8)セチルエーテルなどのポリオキシエチレンポリオキシプロピレンアルキルエーテル;
ポリオキシエチレン(5)ラノリンアルコール、ポリオキシエチレン(10)ラノリンアルコール、ポリオキシエチレン(20)ラノリンアルコールなどのポリオキシエチレンアルキルアルコール;
ポリオキシエチレンポリオキシプロピレングリコール;ポリオキシエチレンポリオキシプロピレンアルキルグリコール;
モノオレイン酸ポリオキシエチレン(5)グリセリル、モノオレイン酸ポリオキシエチレン(15)グリセリルなどのポリオキシエチレングリセリル;
Polyoxyethylene alkenyl such as polyoxyethylene (7) oleyl ether, polyoxyethylene (10) oleyl ether, polyoxyethylene (15) oleyl ether, polyoxyethylene (20) oleyl ether, polyoxyethylene (50) oleyl ether ether;
Polyoxyethylene poly, such as polyoxyethylene (1) polyoxypropylene (4) cetyl ether, polyoxyethylene (10) polyoxypropylene (4) cetyl ether, polyoxyethylene (1) polyoxypropylene (8) cetyl ether Oxypropylene alkyl ether;
Polyoxyethylene alkyl alcohols such as polyoxyethylene (5) lanolin alcohol, polyoxyethylene (10) lanolin alcohol, polyoxyethylene (20) lanolin alcohol;
Polyoxyethylene polyoxypropylene glycol; polyoxyethylene polyoxypropylene alkyl glycol;
Polyoxyethylene glyceryl such as polyoxyethylene (5) glyceryl monooleate, polyoxyethylene (15) glyceryl monooleate;
ポリオキシエチレン(3)ヒマシ油、ポリオキシエチレン(10)ヒマシ油、ポリオキシエチレン(20)ヒマシ油、ポリオキシエチレン(40)ヒマシ油、ポリオキシエチレン(50)ヒマシ油、ポリオキシエチレン(60)ヒマシ油、ポリオキシエチレン(5)硬化ヒマシ油、ポリオキシエチレン(10)硬化ヒマシ油、ポリオキシエチレン(20)硬化ヒマシ油、ポリオキシエチレン(30)硬化ヒマシ油、ポリオキシエチレン(40)硬化ヒマシ油、ポリオキシエチレン(50)硬化ヒマシ油、ポリオキシエチレン(60)硬化ヒマシ油、ポリオキシエチレン(80)硬化ヒマシ油などのポリオキシエチレン化ヒ
マシ油;
モノラウリン酸ポリオキシエチレン(6)ソルビット、モノラウリン酸ポリオキシエチレン(20)ソルビタン、モノパルミチン酸ポリオキシエチレン(20)ソルビタン、モノステアリン酸ポリオキシエチレン(6)ソルビタン、モノステアリン酸ポリオキシエチレン(20)ソルビタン、モノイソステアリン酸ポリオキシエチレン(20)ソルビタン、トリステアリン酸ポリオキシエチレン(20)ソルビタン、モノオレイン酸ポリオキシエチレン(6)ソルビタン、モノオレイン酸ポリオキシエチレン(20)ソルビタン、トリオレイン酸ポリオキシエチレン(20)ソルビタン、ポリオキシエチレン(20)ヤシ油脂肪酸ソルビタン、モノラウリン酸ポリオキシエチレン(10〜80)ソルビタン、トリステアリン酸ポリオキシエチレンソルビタン、イソステアリン酸ポリオキシエチレン(20)ソルビタン、トリステアリン酸ポリオキシエチレン(150)ソルビタン、テトラオレイン酸ポリオキシエチレン(6)ソルビット、テトラオレイン酸ポリオキシエチレン(30)ソルビット、テトラオレイン酸ポリオキシエチレン(40)ソルビット、テトラオレイン酸ポリオキシエチレン(60)ソルビットなどのポリオキシエチレンソルビタン脂肪酸エステル;
Polyoxyethylene (3) castor oil, polyoxyethylene (10) castor oil, polyoxyethylene (20) castor oil, polyoxyethylene (40) castor oil, polyoxyethylene (50) castor oil, polyoxyethylene (60 ) Castor oil, polyoxyethylene (5) hydrogenated castor oil, polyoxyethylene (10) hydrogenated castor oil, polyoxyethylene (20) hydrogenated castor oil, polyoxyethylene (30) hydrogenated castor oil, polyoxyethylene (40) Polyoxyethylenated castor oil, such as hydrogenated castor oil, polyoxyethylene (50) hydrogenated castor oil, polyoxyethylene (60) hydrogenated castor oil, polyoxyethylene (80) hydrogenated castor oil;
Polyoxyethylene (6) sorbitol monolaurate, polyoxyethylene (20) sorbitan monolaurate, polyoxyethylene (20) sorbitan monopalmitate, polyoxyethylene (6) sorbitan monostearate, polyoxyethylene monostearate (20 ) Sorbitan, polyoxyethylene monoisostearate (20) sorbitan, polyoxyethylene tristearate (20) sorbitan, polyoxyethylene monooleate (6) sorbitan, polyoxyethylene monooleate (20) sorbitan, trioleic acid Polyoxyethylene (20) sorbitan, polyoxyethylene (20) palm oil fatty acid sorbitan, polyoxyethylene (10-80) sorbitan monolaurate, polyoxyethylene tristearate Sorbitan, polyoxyethylene (20) sorbitan isostearate, polyoxyethylene (150) sorbitan tristearate, polyoxyethylene (6) sorbitol tetraoleate, polyoxyethylene (30) sorbitol tetraoleate, polytetraoleate poly Polyoxyethylene sorbitan fatty acid esters such as oxyethylene (40) sorbit, polyoxyethylene tetraoleate (60) sorbit;
モノラウリン酸ソルビタン、モノパルミチン酸ソルビタン、モノステアリン酸ソルビタン、モノイソステアリン酸ソルビタン、モノオレイン酸ソルビタン、セスキステアリン酸ソルビタン、セスキイソステアリン酸ソルビタン、セスキオレイン酸ソルビタン、トリステアリン酸ソルビタン、トリオレイン酸ソルビタン、ヤシ油脂肪酸ソルビタン、イソステアリン酸ソルビタン、セスキイソステアリン酸ソルビタン、ジステアリン酸ソルビタンなどのソルビタン脂肪酸エステル;
多価アルコール脂肪酸部分エステル;ポリオキシエチレン多価アルコール脂肪酸部分エステル;ポリオキシエチレン脂肪酸モノ(ジ)エステル;ポリグリセリン脂肪酸エステル;
ポリオキシエチレン(5)オレイン酸アミドなどのポリオキシエチレン脂肪酸アミド;脂肪酸ジエタノールアミド;ポリオキシエチレンアルキルアミン;トリエタノールアミン脂肪酸部分エステル;トリアルキルアミンオキサイド;
ポリオキシエチレン・メチルポリシロキサン共重合体(ジメチコンコポリオール)、アミノエチルアミノプロピルシロキサン・ジメチルシロキサン共重合体(アモジメチコン)などのシリコーン系非イオン性界面活性剤が挙げられる。
Sorbitan monolaurate, sorbitan monopalmitate, sorbitan monostearate, sorbitan monoisostearate, sorbitan monooleate, sorbitan sesquistearate, sorbitan sesquiisostearate, sorbitan sesquioleate, sorbitan tristearate, sorbitan trioleate, coconut Sorbitan fatty acid esters such as oil fatty acid sorbitan, sorbitan isostearate, sorbitan sesquiisostearate, sorbitan distearate;
Polyhydric alcohol fatty acid partial ester; Polyoxyethylene polyhydric alcohol fatty acid partial ester; Polyoxyethylene fatty acid mono (di) ester; Polyglycerin fatty acid ester;
Polyoxyethylene fatty acid amides such as polyoxyethylene (5) oleic acid amide; fatty acid diethanolamide; polyoxyethylene alkylamine; triethanolamine fatty acid partial ester; trialkylamine oxide;
Examples thereof include silicone-based nonionic surfactants such as polyoxyethylene / methylpolysiloxane copolymer (dimethicone copolyol) and aminoethylaminopropylsiloxane / dimethylsiloxane copolymer (amodimethicone).
これらは1種単独であるいは2種以上組み合わせて用いることができる。
これらのうち、乳化作用の強さと、取り扱いの容易さの点からは、ポリオキシエチレン付加モル数10〜100の、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンアルケニルエーテル、ポリオキシエチレンアルキルフェニルエーテルからなる群から選ばれる少なくとも1種が好ましく挙げられる。また、毛髪への滑り、帯電防止効果の付与を期待できる点からは、シリコーン系非イオン性界面活性剤も好ましく用いられる。該シリコーン系非イオン性界面活性剤は、ポリエーテル変性シリコーンオイル、アミノ変性シリコーンオイルなどとして知られるものであるが、非イオン性界面活性剤としての挙動を示すため、本明細書中では界面活性剤として分類する。市販品としては、たとえば、SH3771M(東レ・ダウコーニング・シリコーン株式会社)、SM8704C(東レ・ダウコーニング・シリコーン株式会社)などが挙げられる。
These can be used alone or in combination of two or more.
Among these, from the viewpoint of the strength of emulsification and the ease of handling, it is composed of polyoxyethylene alkyl ether, polyoxyethylene alkenyl ether, polyoxyethylene alkylphenyl ether having a polyoxyethylene addition mole number of 10 to 100. Preferred is at least one selected from the group. In addition, silicone-based nonionic surfactants are also preferably used from the viewpoint of expecting slipping to hair and imparting an antistatic effect. The silicone-based nonionic surfactant is known as a polyether-modified silicone oil, an amino-modified silicone oil, etc., but exhibits a behavior as a nonionic surfactant. Classify as an agent. Examples of commercially available products include SH3771M (Toray Dow Corning Silicone Co., Ltd.), SM8704C (Toray Dow Corning Silicone Co., Ltd.), and the like.
陽イオン性界面活性剤としては、
塩化セチルトリメチルアンモニウム、塩化ステアリルトリメチルアンモニウム、塩化ラウリルトリメチルアンモニウム、塩化ベヘニルトリメチルアンモニウム、塩化ジステアリルジメチルアンモニウム、塩化ジココイルジメチルアンモニウム、塩化ジメチルジアリルアンモニウム−アクリル酸共重合体、塩化ジメチルジアリルアンモニウム−アクリル酸−アクリルアミド3元共重合体、塩化ベンザルコニウム、塩化セチルピリジニウム、塩化ベ
ンゼトニウム、ラノリン誘導第4級アンモニウム、アミドアミン類、ステアリン酸ジメチルアミノプロピルアミド、ステアリン酸ジエチルアミノエチルアミド、特開2004-176070
号公報に記載されたシリコーン系陽イオン性界面活性剤(分子中に第4級アンモニウム基を有するシランまたはシロキサン)などが挙げられる。
As a cationic surfactant,
Cetyltrimethylammonium chloride, stearyltrimethylammonium chloride, lauryltrimethylammonium chloride, behenyltrimethylammonium chloride, distearyldimethylammonium chloride, dicocoyldimethylammonium chloride, dimethyldiallylammonium chloride-acrylic acid copolymer, dimethyldiallylammonium chloride-acrylic acid Acrylamide terpolymer, benzalkonium chloride, cetylpyridinium chloride, benzethonium chloride, lanolin-derived quaternary ammonium, amidoamines, dimethylaminopropylamide stearate, diethylaminoethylamide stearate, JP2004-176070
And silicone-based cationic surfactants (silanes or siloxanes having a quaternary ammonium group in the molecule) described in Japanese Patent Publication No. JP-A No. 2004-26883.
陰イオン性界面活性剤としては、脂肪酸塩;ポリオキシエチレンアルキルエーテルメチルカルボン酸塩;アルキルベンゼンスルホン酸塩;アルキルナフタレンスルホン酸塩;アルキルスルホン酸塩;α-オレフィンスルホン酸塩;ナフタレンスルホン酸塩ホルマリン
縮合物;スルホコハク酸ジオクチルナトリウムなどのジアルキルスルホコハク酸エステル塩;ジソジウムアルキルアミドエチルスルホコハク酸エステル;α−スルホン化脂肪族アルキルエステル塩;ソジウムアルキルイセチネート;石油スルホン酸塩;ラウリル硫酸ナトリウムなどのアルキル硫酸塩;ラウリルエーテル硫酸アンモニウムなどのアルキルエーテル硫酸塩;硫酸化油脂;ポリオキシエチレン(2,5)ラウリル硫酸ナトリウムなどのポリオキシエチレンアルキル硫酸塩;ポリオキシエチレンアルキルエーテル硫酸塩;ポリオキシエチレンアルキルフェニルエーテル硫酸塩;ポリオキシエチレンスチレン化フェニルエーテル硫酸塩;アルキルリン酸塩;ポリオキシエチレンアルキルエーテルリン酸塩;ポリオキシエチレンアルキルフェニルエーテルリン酸塩;ナトリウムN−メチル−N−オレイルタウリンなどのN−アシル−N−メチルタウリン塩などが挙げられる。
Examples of anionic surfactants include fatty acid salts; polyoxyethylene alkyl ether methyl carboxylates; alkylbenzene sulfonates; alkyl naphthalene sulfonates; alkyl sulfonates; α-olefin sulfonates; Condensate; Dialkylsulfosuccinic acid ester salt such as dioctyl sodium sulfosuccinate; Disodium alkylamidoethyl sulfosuccinic acid ester; α-sulfonated aliphatic alkyl ester salt; Sodium alkyl isethinate; Petroleum sulfonate; Sodium lauryl sulfate, etc. Alkyl sulfates; alkyl ether sulfates such as ammonium lauryl ether sulfate; sulfated oils and fats; polyoxyethylene alkyl sulfates such as polyoxyethylene (2,5) sodium lauryl sulfate Polyoxyethylene alkyl ether sulfate; polyoxyethylene alkyl phenyl ether sulfate; polyoxyethylene styrenated phenyl ether sulfate; alkyl phosphate; polyoxyethylene alkyl ether phosphate; polyoxyethylene alkyl phenyl ether phosphate Salts; N-acyl-N-methyl taurine salts such as sodium N-methyl-N-oleyl taurine and the like.
両性界面活性剤としては、N,N-ジメチル-N-アルキル-N-カルボキシメチルアンモニオベタイン、N,N,N-トリメチル-N-アルキレンアンモニオカルボキシベタイン、ラウリルジメ
チルアミノ酢酸ベタイン、ヤシ油脂肪酸アミドプロピルジメチルアミノ酢酸ベタインなどのカルボキシベタイン類;
N-アシルアミドプロピル-N',N'-ジメチル-N'-β-ヒドロキシプロピレンアンモニオスルホベタインなどのスルホベタイン類;
N,N-ジアルキル-N,N-ビス(ポリオキシエチレン硫酸)アンモニオベタイン;
2-アルキル-1-ヒドロキシエチル-1-カルボキシメチルイミダゾリウニウムベタインなどのイミダゾリニウムベタイン類;
N−ヤシ油脂肪酸アシル−N−カルボキシメチル−N−ヒドロキシエチルエチレンジアミンナトリウム、N−ヤシ油脂肪酸アシル−N−カルボキシメチル−N−ヒドロキシエチルエチレンジアミン・ラウリル硫酸ナトリウムなどが挙げられる。
Amphoteric surfactants include N, N-dimethyl-N-alkyl-N-carboxymethylammoniobetaine, N, N, N-trimethyl-N-alkyleneammoniocarboxybetaine, lauryldimethylaminoacetic acid betaine, coconut oil fatty acid Carboxybetaines such as amidopropyldimethylaminoacetic acid betaine;
Sulfobetaines such as N-acylamidopropyl-N ′, N′-dimethyl-N′-β-hydroxypropylene ammoniosulfobetaine;
N, N-dialkyl-N, N-bis (polyoxyethylene sulfate) ammoniobetaine;
Imidazolinium betaines such as 2-alkyl-1-hydroxyethyl-1-carboxymethylimidazolium betaine;
N-coconut oil fatty acid acyl-N-carboxymethyl-N-hydroxyethylethylenediamine sodium, N-coconut oil fatty acid acyl-N-carboxymethyl-N-hydroxyethylethylenediamine, sodium lauryl sulfate and the like can be mentioned.
高分子界面活性剤としては、アクリル酸・メタアクリル酸共重合体、ポリアクリルアミド、ポリアクリル酸ナトリウムなどが挙げられる。
バイオサーファクタントとしては、レシチン、水添レシチン、サポニン、サーファクチン類および/またはその塩などが挙げられる。ここで、バイオサーファクタントとは、原
核生物がその生命活動の中で合成する界面活性剤様の性質を有する物質を意味する。このうち、サーファクチン類とは、下記式(2)で示されるリポペプチド構造を有する化合物および/またはその類縁化合物、あるいはこれらの化合物を2種以上含有する組成物であ
る。
Examples of the polymer surfactant include acrylic acid / methacrylic acid copolymer, polyacrylamide, and sodium polyacrylate.
Examples of the biosurfactant include lecithin, hydrogenated lecithin, saponin, surfactins and / or salts thereof. Here, the biosurfactant means a substance having a surfactant-like property that a prokaryote synthesizes during its life activity. Among these, surfactins are compounds having a lipopeptide structure represented by the following formula (2) and / or related compounds thereof, or compositions containing two or more of these compounds.
上記式(2)において、Xは、ロイシン、イソロイシン、バリン、グリシン、セリン、アラニン、トレオニン、アスパラギン、グルタミン、アスパラギン酸、グルタミン酸、リ
ジン、アルギニン、システイン、メチオニン、フェニルアラニン、チロシン、トリプトファン、ヒスチジン、プロリン、4−ヒドロキシプロリン及びホモセリンからなる群から選ばれるアミノ酸残基を表す。これらのうち、好ましいXはロイシン、イソロイシンまたはバリンである。
In the above formula (2), X is leucine, isoleucine, valine, glycine, serine, alanine, threonine, asparagine, glutamine, aspartic acid, glutamic acid, lysine, arginine, cysteine, methionine, phenylalanine, tyrosine, tryptophan, histidine, proline. Represents an amino acid residue selected from the group consisting of 4-hydroxyproline and homoserine. Of these, preferred X is leucine, isoleucine or valine.
Rは、炭素原子数8〜14のノルマルアルキル基、炭素原子数8〜14のイソアルキル基または炭素原子数8〜14のアンテイソアルキル基である。ノルマルアルキル基は直鎖アルキル基、イソアルキル基は通常(CH3)2CH−(CH2)n−からなる基であり、アンテイソアルキル基は通常CH3−CH2−CH(CH3)−(CH2)n−からなる基であ
る。
R is a normal alkyl group having 8 to 14 carbon atoms, an isoalkyl group having 8 to 14 carbon atoms, or an anteisoalkyl group having 8 to 14 carbon atoms. The normal alkyl group is a linear alkyl group, the isoalkyl group is usually a group consisting of (CH 3 ) 2 CH— (CH 2 ) n —, and the anteisoalkyl group is usually CH 3 —CH 2 —CH (CH 3 ) —. A group consisting of (CH 2 ) n —.
前記類縁化合物とは、式(2)のアミノ酸の一部が他のアミノ酸に置き換わったものをいう。具体的には2番目のL−ロイシン、4番目のL−バリン、6番目のD−ロイシン等が他のアミノ酸に置き換わったものが挙げられるが、これらに限定されない。 The related compound refers to a compound in which a part of the amino acid of the formula (2) is replaced with another amino acid. Specific examples include, but are not limited to, those in which the second L-leucine, the fourth L-valine, the sixth D-leucine and the like are replaced with other amino acids.
サーファクチン類は、通常は原核生物により生産されるが、他の製法、たとえば化学合成法によって得られるものも同様に使用することができる。原核生物としては、一般にバチルスズブチリス(Bacillus subtilis)IAM 1213株、IAM 1069株、IAM 1259株、IAM 1260株、IFO 3035株、ATCC 21332株等のバチルス属微生物が用いられる。 Surfactins are normally produced by prokaryotes, but other production methods such as those obtained by chemical synthesis can be used as well. As prokaryotes, Bacillus subtilis IAM 1213 strain, IAM 1069 strain, IAM 1259 strain, IAM 1260 strain, IFO 3035 strain, ATCC 21332 strain, and other microorganisms belonging to the genus Bacillus are generally used.
サーファクチン類の塩としては、ナトリウム、カリウム、リチウム等のアルカリ金属塩、カルシウム、マグネシウム等のアルカリ土類金属塩、トリメチルアミン、トリエチルアミン、トリブチルアミン、モノエタノールアミン、ジエタノールアミン、トリエタノールアミン、リジン、アルギニン、コリンなどの有機塩を挙げることができる。これらのうち、サーファクチン類のナトリウム塩としては、サーファクチンナトリウムとして昭和電工株式会社からアミノフェクト(R)(昭和電工株式会社登録商標)の商品名で販売されているものを使用することができる。 Surfactin salts include alkali metal salts such as sodium, potassium and lithium, alkaline earth metal salts such as calcium and magnesium, trimethylamine, triethylamine, tributylamine, monoethanolamine, diethanolamine, triethanolamine, lysine and arginine. And organic salts such as choline. Among these, as surfactin sodium salts, those sold under the trade name of Aminofect (R) (registered trademark of Showa Denko KK) from Showa Denko as Surfactin Sodium can be used. .
本発明の毛髪処理用薬剤に用いることのできる水としては、とくに限定されないが、イオン交換水、蒸留水、精製水などの精製工程を経たものが好ましい。
毛髪処理用薬剤
本発明の毛髪処理用薬剤は、少なくとも上記式(1)で示される環状メルカプト化合物、界面活性剤、および水を含み、かつ乳化している。
The water that can be used for the hair treatment agent of the present invention is not particularly limited, but water that has undergone a purification step such as ion-exchanged water, distilled water, or purified water is preferred.
Hair Treatment Agent The hair treatment agent of the present invention contains at least a cyclic mercapto compound represented by the above formula (1), a surfactant, and water and is emulsified.
この毛髪処理用薬剤としては、パーマネントウエーブ加工用薬剤、毛髪矯正剤などが好ましく挙げられる。毛髪矯正剤は、主として、毛髪のくせ毛直し、カール伸ばし、いわゆる寝ぐせの改善のほか、カール形成などにも好適に使用される薬剤であり、パーマネントウエーブ用加工用薬剤で一般に行われる臭素酸塩や過酸化水素による酸化処理を必要としない。 Preferred examples of the hair treatment agent include permanent wave processing agents and hair straighteners. Hair straighteners are mainly used to improve hair curling, curl stretching, so-called sleepiness, and curling, as well as bromates commonly used in permanent wave processing agents. No oxidation treatment with hydrogen peroxide is required.
上記毛髪矯正剤は、用途には特に制限はなく、例えば、シャンプー、リンス、コンディショナー、ヘアトリートメント、ヘアウオーター、ヘアワックス、ヘアムース、頭髪用ジェルなどとして用いられる。これらの中では、シャンプー、リンス、コンディショナー、ヘアトリートメント、ヘアウオーター、またはヘアムースからなる群より選ばれるいずれかの毛髪化粧料として好ましく用いられる。 The use of the hair straightener is not particularly limited, and for example, it is used as a shampoo, rinse, conditioner, hair treatment, hair water, hair wax, hair mousse, hair gel, and the like. Among these, it is preferably used as any hair cosmetic selected from the group consisting of shampoos, rinses, conditioners, hair treatments, hair waters, or hair mousses.
本発明の毛髪処理用薬剤をパーマネントウエーブ加工用薬剤として使用する場合、上記式(1)で表される環状メルカプト化合物が還元物質の含有率(チオグリコール酸として)で、好ましくは0.2〜30%、より好ましくは1〜15%となる量で含有されている。環状メルカプト化合物の含有率がこの範囲にあれば、毛髪や皮膚へのダメージがなく、
ウエーブ効率を高く保持することができる。
When the hair treatment agent of the present invention is used as a permanent wave processing agent, the cyclic mercapto compound represented by the above formula (1) is preferably a content of reducing substance (as thioglycolic acid), preferably 0.2 to It is contained in an amount of 30%, more preferably 1 to 15%. If the content of the cyclic mercapto compound is within this range, there is no damage to the hair and skin,
Wave efficiency can be kept high.
還元物質の含有率が0.2%未満では、パーマネントウエーブ加工用薬剤としての性能が全くでない場合がある。一方、30%を越えると、モンゴロイド系人種の場合には、毛髪の極端な縮毛、キューティクルの部分剥離が促進されることで毛髪ダメージが大きくなることがある。 When the content of the reducing substance is less than 0.2%, the performance as a permanent wave processing chemical may not be obtained at all. On the other hand, if it exceeds 30%, in the case of a Mongoloid race, hair damage may increase by promoting extreme curly hair and partial peeling of the cuticle.
なお、還元物質の含有率(チオグリコール酸として)とは、チオグリコール酸還元力換算とも言い、医薬部外品に関するパーマネントウエーブ用剤品質規格で施術ごとに定められたケラチン還元性物質濃度の表記法であり、下記の方法(I)〜(III)に準じて測定
された濃度である。
The content of reducing substances (as thioglycolic acid), also referred to as thioglycolic acid reducing power conversion, is a notation of the concentration of keratin reducing substances determined for each treatment in the permanent wave quality standards for quasi-drugs. This is a concentration measured according to the following methods (I) to (III).
(I)試料10mLを100mLのメスフラスコに取り、化粧品原料基準に適合する精製水(以下、単に「水」と記載する。)を加えて全量を100mLとし、これを試験溶液とする。 (I) Take 10 mL of a sample in a 100 mL volumetric flask and add purified water (hereinafter simply referred to as “water”) that conforms to cosmetic raw material standards to make the total volume 100 mL, which is used as a test solution.
(II)試験溶液20mLを正確に取り、水50mLおよび30%硫酸5mLを加え、穏やかに加熱し、5分間煮沸する。冷却後、0.1Nヨウ素液で滴定し、その消費量をAmLとする(指示薬:デンプン試液 3mL)。 (II) Take exactly 20 mL of the test solution, add 50 mL of water and 5 mL of 30% sulfuric acid, gently heat and boil for 5 minutes. After cooling, titrate with 0.1N iodine solution, and the amount of consumption is AmL (indicator: starch sample solution 3 mL).
(III)得られた滴定結果を下式によりチオグリコール酸換算の含有率として算出する
。
還元物質の含有率(チオグリコール酸として)(%)=0.4606×A
なお、化粧品分類のパーマネントウエーブ用剤(カーリング剤)は、パーマネントウエーブ工業会で自主規制値を設定しており、同様の測定方法により使用量が規定されている。
(III) The obtained titration result is calculated as a thioglycolic acid content by the following formula.
Reducing substance content (as thioglycolic acid) (%) = 0.4606 × A
In addition, the permanent wave agent (curling agent) for cosmetics classification has a self-regulated value set by the Permanent Wave Industry Association, and the amount used is regulated by the same measurement method.
また、本発明の毛髪処理用薬剤を毛髪矯正剤として使用する場合、上記式(1)で表される環状メルカプト化合物は通常0.01〜15質量%、より好ましくは0.1〜10質量%、さらに好ましくは1〜5質量%の量で含有される。上記環状メルカプト化合物の含有量がこの範囲にあれば、期待される毛髪矯正効果を充分に発揮することができる。 Moreover, when using the hair treatment chemical | medical agent of this invention as a hair straightener, the cyclic mercapto compound represented by the said Formula (1) is 0.01-15 mass% normally, More preferably, it is 0.1-10 mass%. More preferably, it is contained in an amount of 1 to 5% by mass. If the content of the cyclic mercapto compound is within this range, the expected hair straightening effect can be sufficiently exhibited.
その一方、環状メルカプト化合物の含有量が上記下限値未満では毛髪矯正効果がほとんど発揮されない場合があり、上記上限値を超えると臭気が強くなるので実用的でない場合がある。このように毛髪矯正剤として使用した場合は、毛髪への塗布後、櫛による整髪あるいは洗髪までの比較的短い時間で、くせ毛やカールの矯正ができ、さらに、毛髪のソフト感が向上する。その理由は、定かではないが、上記式(1)で示される環状メルカプト化合物を使用することによって、剤の親油性が増し、毛髪への浸透性が向上するために短時間で効果が現れると推定され、さらには、後述のように弱酸性から中性領域で使用されるために毛髪の損傷などがなくソフト感が得られるものと考えられる。 On the other hand, if the content of the cyclic mercapto compound is less than the above lower limit value, the hair straightening effect may be hardly exhibited, and if the content exceeds the above upper limit value, the odor becomes strong and may not be practical. When used as a hair straightener in this way, after application to the hair, it is possible to straighten the hair and curl in a relatively short time from combing or shampooing, and the hair softness is improved. The reason for this is not clear, but the use of the cyclic mercapto compound represented by the above formula (1) increases the lipophilicity of the agent and improves the permeability to hair, so that the effect appears in a short time. Further, as described later, since it is used in a weakly acidic to neutral region as described later, it is considered that there is no hair damage and a soft feeling can be obtained.
さらに本発明の毛髪処理用薬剤には、前記界面活性剤が、好ましくは0.02〜15質量%、より好ましくは0.1〜10質量%の量で含まれている。このような量で界面活性剤を配合することにより、上記環状メルカプト化合物を、水の存在下においても、充分に乳化させることができ、パーマネントウエーブ加工用薬剤、毛髪矯正剤などの毛髪処理用薬剤中での上記環状メルカプト化合物の経時による分解を抑制することができる。また、乳化した薬剤中で、上記環状メルカプト化合物はミセル内の親油性領域に存在するため、環状メルカプト化合物の臭気をマスキングする効果も有する。 Further, the surfactant for hair treatment of the present invention preferably contains the surfactant in an amount of 0.02 to 15% by mass, more preferably 0.1 to 10% by mass. By blending the surfactant in such an amount, the cyclic mercapto compound can be sufficiently emulsified even in the presence of water, and a hair treatment agent such as a permanent waving agent or a hair straightener. It is possible to suppress degradation of the cyclic mercapto compound in the medium over time. Moreover, since the said cyclic mercapto compound exists in the lipophilic area | region in a micelle in the emulsified chemical | medical agent, it also has an effect which masks the odor of a cyclic mercapto compound.
本発明の毛髪処理用薬剤を調製する方法は特に限定されず、上記式(1)で示される特
定の環状メルカプト化合物を、上記界面活性剤を用いて、溶剤としての水に乳化させることができればよく、混合手法や混合順序、混合条件などは問わない。
The method for preparing the hair treatment agent of the present invention is not particularly limited as long as the specific cyclic mercapto compound represented by the formula (1) can be emulsified in water as a solvent using the surfactant. The mixing method, mixing order, mixing conditions, etc. are not particularly limited.
本発明の毛髪処理用薬剤は、上記式(1)で示される環状メルカプト化合物、界面活性剤、および水を含み、乳化している限り、特にその形態に制限はなく、例えば、液状、泡状、ゲル状、クリーム状、ペーストなどの形態で使用可能である。そして、その形態によって液タイプ、スプレータイプ、エアゾールタイプ、クリームタイプ、ゲルタイプ等、種々のタイプの薬剤として使用できる。 The agent for treating hair of the present invention includes a cyclic mercapto compound represented by the above formula (1), a surfactant, and water, and as long as it is emulsified, its form is not particularly limited. , Gel, cream, paste and the like. And according to the form, it can be used as various types of drugs such as liquid type, spray type, aerosol type, cream type and gel type.
さらに、本発明の毛髪処理用薬剤には、毛髪の加工性能を向上させる目的および使用形態に応じて、種々の添加剤を配合してもよい。添加剤としては、膨潤剤、浸透促進剤、緩衝剤、油剤、増粘剤、毛髪保護剤、湿潤剤、pH調整剤、香料、染料、安定化剤、臭気マスキング剤などを用いることができる。 Furthermore, you may mix | blend various additives with the chemical | medical agent for hair treatment of this invention according to the objective and the usage form which improve the processing performance of hair. As additives, swelling agents, penetration enhancers, buffers, oil agents, thickeners, hair protecting agents, wetting agents, pH adjusting agents, fragrances, dyes, stabilizers, odor masking agents and the like can be used.
膨潤剤、浸透促進剤としては、エタノール、プロパノール、イソプロパノール、1,2−プロピレングリコール、1,3−ブタンジオール、グリセリン、エチルカルビトール、ベンジルアルコール、ベンジルオキシエタノール、尿素、ベンジルアミン、2−メチルピロリドンなどが挙げられる。 As swelling agents and penetration enhancers, ethanol, propanol, isopropanol, 1,2-propylene glycol, 1,3-butanediol, glycerin, ethyl carbitol, benzyl alcohol, benzyloxyethanol, urea, benzylamine, 2-methyl Examples include pyrrolidone.
緩衝剤としては、無機緩衝剤のほか、アルギニン、リジンなどの塩基性アミノ酸を含む緩衝剤が挙げられる。
油剤としては、パラフィン、流動パラフィン、ミツロウ、スクワラン、ホホバ油、オリーブ油、エステル油、トリグリセリド、ワセリン、ラノリンなどが挙げられる。
Examples of the buffer include inorganic buffers and buffers containing basic amino acids such as arginine and lysine.
Examples of the oil include paraffin, liquid paraffin, beeswax, squalane, jojoba oil, olive oil, ester oil, triglyceride, petrolatum, lanolin and the like.
増粘剤としては、カルボキシメチルセルロース、カルボキシビニルポリマー、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、キサンタンガム、カラギーナン、アルギン酸塩、ペクチン、トラガントガム、ラウリルアルコール、セチルアルコール、ステアリルアルコール、イソステアリルアルコール、オレイルアルコール、ベヘニルアルコールなどの高級アルコール、カオリン、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘニン酸、オレイン酸、ウンデシル酸、イソステアリン酸などの脂肪酸、ワセリンなどが挙げられる。 Thickeners include carboxymethylcellulose, carboxyvinyl polymer, hydroxyethylcellulose, hydroxypropylcellulose, xanthan gum, carrageenan, alginate, pectin, tragacanth gum, lauryl alcohol, cetyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, behenyl alcohol, etc. Examples include higher alcohols, kaolin, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, undecyl acid, isostearic acid and other fatty acids, petrolatum, and the like.
毛髪保護成分としては、コラーゲンやケラチンなどの加水分解物およびその誘導体などが挙げられる。
湿潤剤としては、グリセリン、ジグリセリン、プロピレングリコール、ジプロピレングリコール、1,3−ブタンジオール、ソルビトール、植物抽出エキス、ビタミン類、ヒアルロン酸塩、コンドロイチン硫酸塩などが挙げられる。
Examples of the hair protecting component include hydrolysates such as collagen and keratin, and derivatives thereof.
Examples of the wetting agent include glycerin, diglycerin, propylene glycol, dipropylene glycol, 1,3-butanediol, sorbitol, plant extract, vitamins, hyaluronate, chondroitin sulfate, and the like.
pH調整剤としては、塩酸、リン酸などの無機酸、あるいはリン酸水素二ナトリウム、リン酸二水素ナトリウム等の無機酸塩;クエン酸、リンゴ酸、乳酸、コハク酸、シュウ酸などの有機酸、あるいはそのナトリウム塩;アンモニア、ジエタノールアミン、トリエタノールアミン、水酸化ナトリウム、水酸化カリウム、炭酸ナトリウム、炭酸水素ナトリウム、炭酸カリウム、炭酸水素カリウムなどのアルカリ剤が挙げられる。 Examples of pH adjusters include inorganic acids such as hydrochloric acid and phosphoric acid, or inorganic acid salts such as disodium hydrogen phosphate and sodium dihydrogen phosphate; organic acids such as citric acid, malic acid, lactic acid, succinic acid, and oxalic acid. Or an alkali agent such as ammonia, diethanolamine, triethanolamine, sodium hydroxide, potassium hydroxide, sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate, or the like.
安定剤としては、過剰還元防止を目的として、還元化合物のジスルフィド体のほか、ジチオジグリコール酸などがあげられる。
その他の添加剤としては、キレート剤として、エデト酸およびその金属塩、グルタミン酸4酢酸およびその金属塩、アスパラギン酸4酢酸およびその金属塩、プロピルジアミン4酢酸およびその金属塩などが挙げられる。
Examples of the stabilizer include dithiodiglycolic acid and the like in addition to the disulfide of the reducing compound for the purpose of preventing excessive reduction.
Examples of other additives include edetic acid and its metal salt, glutamic acid 4 acetic acid and its metal salt, aspartic acid 4 acetic acid and its metal salt, propyldiamine tetraacetic acid and its metal salt as chelating agents.
また、本発明の毛髪処理用薬剤には、本発明の効果を損なわない範囲内の量で、従来から知られているケラチン還元物質、たとえば、亜硫酸塩や亜硫酸水素塩のほか、チオグリコール酸およびそのモノグリセロールエステル、チオ乳酸、システイン、アセチルシステイン、システアミン、アシルシステアミンおよびそれらの塩類を併用してもよい。 In addition, the hair treatment agent of the present invention is an amount within the range not impairing the effects of the present invention, and conventionally known keratin reducing substances such as sulfite and bisulfite, thioglycolic acid and The monoglycerol ester, thiolactic acid, cysteine, acetylcysteine, cysteamine, acylcysteamine and salts thereof may be used in combination.
本発明の毛髪処理用薬剤をパーマネントウエーブ加工用薬剤と使用する場合、そのpHについては特に制限は無く、pH9程度のアルカリ性で使用しても良いが、好ましくはpH2.5〜8.7、更に好ましくはpH3.5〜8.0、もっとも好ましくはpH4.0〜7.5の範囲で使用することが望ましい。 When the hair treatment agent of the present invention is used as a permanent wave processing agent, its pH is not particularly limited, and it may be used with an alkalinity of about pH 9, preferably pH 2.5 to 8.7, It is desirable to use in the range of preferably pH 3.5 to 8.0, most preferably pH 4.0 to 7.5.
すなわち、本発明の毛髪処理用薬剤をパーマネントウエーブ加工用薬剤と使用した場合には、パーマネントウエーブ加工用薬剤はアルカリ性であってもパーマネントウエーブ加工効果があるものの、中性、弱酸性になるほどその効果が大きくなる。 That is, when the hair treatment agent of the present invention is used as a permanent wave processing agent, the permanent wave processing agent has a permanent wave processing effect even if it is alkaline, but the effect becomes more neutral and weakly acidic. Becomes larger.
薬剤のpHが上記範囲にあると皮膚刺激性も少なく、毛髪や頭皮の損傷を引き起こす原因とならない。また、本発明に係わる薬剤は、pHを上記範囲内として使用してもパーマネント加工の実用的な性能を発揮することができる。なお、上記範囲内に薬剤のpHを制御するには、例えば上記pH調整剤を薬剤に添加するなどすればよい。 When the pH of the drug is in the above range, there is little skin irritation and it does not cause damage to hair and scalp. Moreover, the chemical | medical agent concerning this invention can exhibit the practical performance of a permanent process even if it uses pH within the said range. In addition, what is necessary is just to add the said pH adjuster to a chemical | medical agent, etc., in order to control the pH of a chemical | medical agent within the said range.
本発明では、上記した環状メルカプト化合物を含んでいるので、皮膚への刺激が少ない中性から弱酸性のpH領域において、毛髪のパーマネントウエーブ加工性能に優れている。 In the present invention, since the cyclic mercapto compound described above is contained, the hair is excellent in the permanent wave processing performance in a neutral to weakly acidic pH range with little irritation to the skin.
また、本発明の毛髪処理用薬剤を該毛髪矯正剤として使用する場合は、アルカリ性側で使用できることは言うまでもないが、従来の毛髪処理剤で使用されているpHよりも低い、弱酸性から中性領域で使用可能であり、むしろ該pH領域でより一層優れた毛髪矯正効果を示す。使用するpHについては特に制限はないが、好ましくはpH2.5〜9.0、更に好ましくはpH3.5〜8.0、特に好ましくはpH4.0〜7.5である。pHが上記範囲にあると皮膚刺激性も少なく、毛髪の損傷などを引き起こす原因となりにくい。 In addition, when the hair treatment agent of the present invention is used as the hair straightener, it goes without saying that it can be used on the alkaline side, but it is lower than the pH used in conventional hair treatment agents, from weakly acidic to neutral. It can be used in an area, and rather shows a better hair straightening effect in the pH area. Although there is no restriction | limiting in particular about pH to be used, Preferably it is pH 2.5-9.0, More preferably, it is pH 3.5-8.0, Most preferably, it is pH 4.0-7.5. When the pH is in the above range, there is little skin irritation and it is difficult to cause damage to hair.
パーマネントウエーブ加工方法
本発明のパーマネントウエーブ加工方法は、上述した毛髪処理用薬剤をパーマネントウエーブ加工用薬剤として使用する限り、その使用方法は特に制限されるものではないが、例えば、毛髪に対するパーマネントウエーブ処理の方法としては、下記(1)〜(4)の工程を有する方法が挙げられる。なお、パーマネントウエーブ処理とは、パーマネントウエーブ形成処理、パーマネントウエーブ処理によるウェーブのばし処理および縮毛矯正処理を含めたものをいう。
(1)パーマネントウエーブ加工用薬剤を毛髪に湿潤し、毛髪に型付けをするためのロッドで巻き込む。なお、縮毛矯正の際には、ロッドを使用しない。また、水巻などで毛髪を固定してからパーマネントウエーブ加工用薬剤を湿潤しても良い。
(2)薬剤を湿潤した後、室温にて放置する。その際、30℃から40℃程度の温度に加温することが好ましい。
(3)酸化剤を含有する組成物によって環状メルカプト化合物を酸化し、毛髪を固定する。
(4)固定した毛髪からロッドを取り外し、毛髪を洗浄、シャンプー処理をし、乾燥する。
Permanent wave processing method The permanent wave processing method of the present invention is not particularly limited as long as the above-described hair treatment agent is used as a permanent wave processing agent. For example, permanent wave treatment for hair is performed. Examples of the method include methods having the following steps (1) to (4). The permanent wave process includes a permanent wave forming process, a wave spreading process using a permanent wave process, and a hair straightening process.
(1) A permanent waving agent is moistened on the hair and wound with a rod for shaping the hair. Note that a rod is not used for straightening hair. Alternatively, the permanent waving agent may be moistened after fixing the hair with a water roll or the like.
(2) After the drug is wetted, it is left at room temperature. In that case, it is preferable to heat to about 30 to 40 degreeC.
(3) The cyclic mercapto compound is oxidized with a composition containing an oxidizing agent to fix the hair.
(4) Remove the rod from the fixed hair, wash the hair, shampoo and dry.
なお、(3)で使用する酸化剤としては、一般的に使用される臭素酸ナトリウムの3〜8質量%程度の水溶液や過酸化水素、過ホウ酸ナトリウムなどの希釈液が使用できる。
本発明によれば、上記したパーマネントウエーブ加工用薬剤を使用しているので、皮膚
に対する影響も少なく、感作性も弱く、さらには毛髪のウエーブ効率にも優れている。
In addition, as an oxidizing agent used by (3), about 3-8 mass% aqueous solution of sodium bromate generally used, and dilution liquids, such as hydrogen peroxide and sodium perborate, can be used.
According to the present invention, since the above-mentioned permanent waving agent is used, there is little influence on the skin, sensitization is weak, and the wave efficiency of the hair is excellent.
以下、実施例に基づいて本発明をさらに具体的に説明するが、本発明はこれらの実施例に限定されるものではない。 EXAMPLES Hereinafter, although this invention is demonstrated further more concretely based on an Example, this invention is not limited to these Examples.
[合成例1]
2−メルカプト−4−ブチロラクトンの製造
70%水硫化ナトリウム(49g、0.6mmol、純正化学株式会社製)をメチルアルコール(500g、純正化学社製、特級)と精製水(蒸留後にイオン交換フィルターを通した水、500g)に溶解した。溶解した液を撹拌しながら氷冷下にて10℃以下まで冷却した。冷却した溶液に2−ブロモ−4−ブチロラクトン(100g、0.6mol、東京化成株式会社製)を約30分かけて滴下した。滴下完了後の液を10分間撹拌した後に、反応液を減圧下で約半量となるまで濃縮した。濃縮した液に、酢酸エチル(500mL、純正化学社製、特級)を加えて抽出した。得られた水相を酢酸エチル(500mL)で再抽出した。これらの抽出した有機相を合わせて、減圧下に濃縮、蒸留精製することで2−メルカプト−4−ブチロラクトン(23g、bp.94℃/0.3kPa、収率32%)を得た。
[Synthesis Example 1]
Manufacture of 2-mercapto-4-butyrolactone 70% sodium hydrosulfide (49 g, 0.6 mmol, manufactured by Junsei Chemical Co., Ltd.) and methyl alcohol (500 g, Junsei Chemical Co., Ltd., special grade) and purified water (ion exchange filter after distillation) Water, 500 g). The dissolved liquid was cooled to 10 ° C. or lower under ice cooling while stirring. To the cooled solution, 2-bromo-4-butyrolactone (100 g, 0.6 mol, manufactured by Tokyo Chemical Industry Co., Ltd.) was added dropwise over about 30 minutes. After the completion of the dropwise addition, the liquid was stirred for 10 minutes, and then the reaction liquid was concentrated to about half volume under reduced pressure. To the concentrated liquid, ethyl acetate (500 mL, manufactured by Junsei Chemical Co., Ltd., special grade) was added for extraction. The resulting aqueous phase was re-extracted with ethyl acetate (500 mL). These extracted organic phases were combined, concentrated under reduced pressure, and purified by distillation to obtain 2-mercapto-4-butyrolactone (23 g, bp. 94 ° C./0.3 kPa, yield 32%).
[実施例1〜15]
ガラス製の300mLトールビーカーに精製水(蒸留後にイオン交換フィルターを通した水)85gをはかり取り、プロピレングリコール3g、リン酸二水素一ナトリウム0.2gとリン酸水素二ナトリウムを表1に記載の量で、室温で加えて、撹拌して完全に溶解した。
[Examples 1 to 15]
85 g of purified water (water passed through an ion exchange filter after distillation) was weighed into a 300 mL tall beaker made of glass, and 3 g of propylene glycol, 0.2 g of monosodium dihydrogen phosphate and disodium hydrogen phosphate were listed in Table 1. The amount was added at room temperature and stirred to dissolve completely.
得られた溶液に表1に記載の界面活性剤を2gずつ加えて概ね均一となるように撹拌した。この溶液をホモミキサーで激しく撹拌しながら、合成例1で合成した2−メルカプト−4−ブチロラクトン2.6gを少しずつ添加した。添加完了後に5分間ホモミキサーで撹拌した。その後に、液重量が100gとなるように精製水を加えた後に、再度ホモミキサーで撹拌してテスト液とした。 2 g of the surfactants listed in Table 1 were added to the obtained solution and stirred so as to be almost uniform. While stirring this solution vigorously with a homomixer, 2.6 g of 2-mercapto-4-butyrolactone synthesized in Synthesis Example 1 was added little by little. After completion of the addition, the mixture was stirred with a homomixer for 5 minutes. Thereafter, purified water was added so that the liquid weight would be 100 g, and the mixture was stirred again with a homomixer to obtain a test liquid.
得られたテスト液の外観は、無色透明の液体あるいは乳白色〜微黄色の乳液状であった。
このようにして得られたテスト液中の2-メルカプト-4-ブチロラクトンの含有量は、
チオグリコール酸還元力換算で2%に相当する。
The appearance of the obtained test solution was a colorless and transparent liquid or a milky white to slightly yellow emulsion.
The content of 2-mercapto-4-butyrolactone in the test solution thus obtained is
It corresponds to 2% in terms of thioglycolic acid reducing power.
このテスト液を調製直後に100mLのフタ付きサンプル瓶に入れて臭いをかぎ、後述する比較例1のテスト液の調製直後の臭気を基準として、臭気の改善具合を以下の評価基準に従い評価した。その後、サンプル瓶のフタを閉め、40℃の恒温槽にて放置した。 Immediately after the preparation, this test solution was put in a 100 mL lidded sample bottle to remove the odor, and the odor improvement was evaluated according to the following evaluation criteria based on the odor immediately after the preparation of the test solution of Comparative Example 1 described later. Thereafter, the lid of the sample bottle was closed and left in a constant temperature bath at 40 ° C.
放置後10日目にテスト液中の2−メルカプト−4−ブチロラクトンの濃度変化を下記の分析条件のもと、高速液体クロマトグラフィーで分析して、2−メルカプト−4−ブチロラクトンの分解率を算出した。さらに、調製直後のテスト液と比較して、この放置後10日目のテスト液の色調変化を目視により評価した。 On the 10th day after standing, the concentration change of 2-mercapto-4-butyrolactone in the test solution was analyzed by high performance liquid chromatography under the following analytical conditions to calculate the decomposition rate of 2-mercapto-4-butyrolactone. did. Furthermore, the color change of the test liquid on the 10th day after the standing was visually evaluated as compared with the test liquid immediately after preparation.
これらの結果およびテスト液のpHを表1に示す。
高速液体クロマトグラフィーの分析条件
Column :Shodex RSpak NN-814 (Column Size:8.0mmφ×250mm)
Eluent :0.008mM-KH2PO4 + 0.1%H3PO4
Flow Rate:1.0mL/min
Detector :UV(210nm), RI
Column temp.:40℃
Inj. Vol. :20μL
臭気評価基準
◎;界面活性剤未添加溶液と比べて大幅な臭気低減をしている。
These results and the pH of the test solution are shown in Table 1.
Analytical conditions for high performance liquid chromatography
Column: Shodex RSpak NN-814 (Column Size: 8.0mmφ × 250mm)
Eluent: 0.008mM-KH 2 PO 4 + 0.1% H 3 PO 4
Flow Rate: 1.0mL / min
Detector: UV (210nm), RI
Column temp .: 40 ℃
Inj. Vol .: 20μL
Odor evaluation criteria ◎; significant reduction in odor compared to non-surfactant added solution.
〇;界面活性剤未添加溶液より臭気低減をしている。
△;界面活性剤未添加溶液より僅かに改善。
×;界面活性剤未添加溶液と同等。
O: The odor is reduced compared to the surfactant-free solution.
Δ: Slightly improved as compared with the surfactant-free solution.
×: Equivalent to a surfactant-free solution.
[比較例1]
ガラス製の300mLトールビーカーに精製水90gをはかり取り、プロピレングリコール3g、リン酸二水素一ナトリウム0.2gとリン酸水素二ナトリウム0.6gを室温で加えて、撹拌して完全に溶解した。
[Comparative Example 1]
90 g of purified water was weighed into a glass 300 mL tall beaker, and 3 g of propylene glycol, 0.2 g of monosodium dihydrogen phosphate and 0.6 g of disodium hydrogen phosphate were added at room temperature, and the mixture was completely dissolved by stirring.
得られた溶液に合成例1で合成した2−メルカプト−4−ブチロラクトン2.6gをホモミキサーで撹拌しながら少しずつ添加した。添加完了後に5分間ホモミキサーで撹拌した。その後に、液重量が100gとなるように精製水を加えた後に、再度ホモミキサーで撹拌してテスト液とした。 To the resulting solution, 2.6 g of 2-mercapto-4-butyrolactone synthesized in Synthesis Example 1 was added little by little while stirring with a homomixer. After completion of the addition, the mixture was stirred with a homomixer for 5 minutes. Thereafter, purified water was added so that the liquid weight would be 100 g, and the mixture was stirred again with a homomixer to obtain a test liquid.
得られたテスト液の外観は、無色透明の溶液であった。
このようにして得られたテスト液中の2-メルカプト-4-ブチロラクトンの含有量は、
チオグリコール酸還元力換算で2%に相当する。
The appearance of the obtained test solution was a colorless and transparent solution.
The content of 2-mercapto-4-butyrolactone in the test solution thus obtained is
It corresponds to 2% in terms of thioglycolic acid reducing power.
このテスト液を調製直後に100mLのフタ付きサンプル瓶に入れて臭いをかぎ、その臭気を上記臭気評価基準の比較用臭気サンプル(界面活性剤未添加溶液の臭気)とした。その後、サンプル瓶のフタを閉め、40℃の恒温槽にて放置した。 Immediately after the preparation, this test solution was put in a 100 mL lidded sample bottle to remove the odor, and the odor was used as a comparative odor sample (odor of a surfactant-free solution) based on the above odor evaluation criteria. Thereafter, the lid of the sample bottle was closed and left in a constant temperature bath at 40 ° C.
放置後10日目にテスト液中の2−メルカプト−4−ブチロラクトンの濃度変化を上記実施例1〜15と同様の条件で、高速液体クロマトグラフィーで分析して、2−メルカプト−4−ブチロラクトンの分解率を算出した。さらに、調製直後のテスト液と比較して、この放置後10日目のテスト液の色調変化を目視により評価した。 On the 10th day after standing, the change in the concentration of 2-mercapto-4-butyrolactone in the test solution was analyzed by high performance liquid chromatography under the same conditions as in Examples 1 to 15 above, and 2-mercapto-4-butyrolactone was analyzed. The degradation rate was calculated. Furthermore, the color change of the test liquid on the 10th day after the standing was visually evaluated as compared with the test liquid immediately after preparation.
これらの結果およびテスト液のpHを表1に示す。 These results and the pH of the test solution are shown in Table 1.
表1より、実施例1〜15のテスト液は、比較例1のテスト液と比較して、40℃で10日間経過した後でも2−メルカプト−4−ブチロラクトンの分解が抑制され、着色が防止されている上に、臭気も改善されていることが分かる。 From Table 1, compared with the test solution of Comparative Example 1, the test solutions of Examples 1 to 15 suppressed the decomposition of 2-mercapto-4-butyrolactone and prevented coloring even after 10 days at 40 ° C. In addition, it can be seen that the odor is improved.
[実施例16〜30]
ガラス製の300mLトールビーカーに精製水65gをはかり取り、プロピレングリコール3g、リン酸二水素一ナトリウム0.3gと、リン酸水素二ナトリウムを表2に記載の量で、室温で加えて、撹拌して完全に溶解した。溶液に表2に記載の界面活性剤を4gずつ加えて概ね均一となるように撹拌した。この溶液をホモミキサーで激しく撹拌しながら、合成例1で合成した2−メルカプト−4−ブチロラクトン2.6gを少しずつ添加した。添加完了後に5分間ホモミキサーで撹拌した。その後に、液重量が100gとなるように精製水を加えた後に、再度ホモミキサーで撹拌してテスト液とした。
[Examples 16 to 30]
In a glass 300 mL tall beaker, 65 g of purified water is weighed, and 3 g of propylene glycol, 0.3 g of monosodium dihydrogen phosphate and disodium hydrogen phosphate are added in the amounts shown in Table 2 at room temperature and stirred. And completely dissolved. 4 g of the surfactant listed in Table 2 was added to the solution and stirred so as to be almost uniform. While stirring this solution vigorously with a homomixer, 2.6 g of 2-mercapto-4-butyrolactone synthesized in Synthesis Example 1 was added little by little. After completion of the addition, the mixture was stirred with a homomixer for 5 minutes. Thereafter, purified water was added so that the liquid weight would be 100 g, and the mixture was stirred again with a homomixer to obtain a test liquid.
このようにして得られたテスト液中の2-メルカプト-4-ブチロラクトンの含有量は、
チオグリコール酸還元力換算で12.7%に相当する。
得られたテスト液の外観は、無色透明の液体あるいは乳白色〜微黄色の乳液状であった。
The content of 2-mercapto-4-butyrolactone in the test solution thus obtained is
It corresponds to 12.7% in terms of thioglycolic acid reducing power.
The appearance of the obtained test solution was a colorless and transparent liquid or a milky white to slightly yellow emulsion.
このテスト液を調製直後に100mLのフタ付きサンプル瓶に入れて臭いをかぎ、後述する比較例2のテスト液の調製直後の臭気を基準として、臭気の改善具合を上記評価基準に従い評価した。その後、サンプル瓶のフタを閉め、40℃の恒温槽にて放置した。 Immediately after the preparation, the test solution was put in a 100 mL lidded sample bottle to remove the odor, and the improvement in odor was evaluated according to the evaluation criteria based on the odor immediately after the preparation of the test solution of Comparative Example 2 described later. Thereafter, the lid of the sample bottle was closed and left in a constant temperature bath at 40 ° C.
放置後10日目にテスト液中の2−メルカプト−4−ブチロラクトンの濃度変化を上記実施例1〜15と同様の条件で、高速液体クロマトグラフィーで分析して、2−メルカプト−4−ブチロラクトンの分解率を算出した。さらに、調製直後のテスト液と比較して、この放置後10日目のテスト液の色調変化を目視により評価した。 On the 10th day after standing, the change in the concentration of 2-mercapto-4-butyrolactone in the test solution was analyzed by high performance liquid chromatography under the same conditions as in Examples 1 to 15 above, and 2-mercapto-4-butyrolactone was analyzed. The degradation rate was calculated. Furthermore, the color change of the test liquid on the 10th day after the standing was visually evaluated as compared with the test liquid immediately after preparation.
これらの結果およびテスト液のpHを表2に示す。
[比較例2]
ガラス製の300mLトールビーカーに精製水70gをはかり取り、プロピレングリコール3g、リン酸二水素一ナトリウム0.3gとリン酸水素二ナトリウム0.8gを室温で加えて、撹拌して完全に溶解した。得られた溶液に合成例1で合成した2−メルカプト−4−ブチロラクトン15gをホモミキサーで撹拌しながら少しずつ添加した。添加完了後に5分間ホモミキサーで撹拌した。その後に、液重量が100gとなるように精製水を加えた後に、再度ホモミキサーで撹拌してテスト液とした。
These results and the pH of the test solution are shown in Table 2.
[Comparative Example 2]
70 g of purified water was weighed into a glass 300 mL tall beaker, and 3 g of propylene glycol, 0.3 g of monosodium dihydrogen phosphate and 0.8 g of disodium hydrogen phosphate were added at room temperature, and the mixture was stirred and completely dissolved. To the obtained solution, 15 g of 2-mercapto-4-butyrolactone synthesized in Synthesis Example 1 was added little by little while stirring with a homomixer. After completion of the addition, the mixture was stirred with a homomixer for 5 minutes. Thereafter, purified water was added so that the liquid weight would be 100 g, and the mixture was stirred again with a homomixer to obtain a test liquid.
得られたテスト液の外観は、無色の液状であるが僅かに油状の物質が溶け残っていた。
このようにして得られたテスト液中の2-メルカプト-4-ブチロラクトンの含有量は、
チオグリコール酸還元力換算で12.7%に相当する。
The appearance of the obtained test solution was a colorless liquid, but a slightly oily substance remained undissolved.
The content of 2-mercapto-4-butyrolactone in the test solution thus obtained is
It corresponds to 12.7% in terms of thioglycolic acid reducing power.
このテスト液を調製直後に100mLのフタ付きサンプル瓶に入れて臭いをかぎ、その臭気を上記臭気評価基準の比較用臭気サンプル(界面活性剤未添加溶液の臭気)とした。その後、サンプル瓶のフタを閉め、40℃の恒温槽にて放置した。 Immediately after the preparation, this test solution was put in a 100 mL lidded sample bottle to remove the odor, and the odor was used as a comparative odor sample (odor of a surfactant-free solution) based on the above odor evaluation criteria. Thereafter, the lid of the sample bottle was closed and left in a constant temperature bath at 40 ° C.
放置後10日目にテスト液中の2−メルカプト−4−ブチロラクトンの濃度変化を上記実施例1〜15と同様の条件で、高速液体クロマトグラフィーで分析して、2−メルカプト−4−ブチロラクトンの分解率を算出した。さらに、調製直後のテスト液と比較して、この放置後10日目のテスト液の色調変化を目視により評価した。 On the 10th day after standing, the change in the concentration of 2-mercapto-4-butyrolactone in the test solution was analyzed by high performance liquid chromatography under the same conditions as in Examples 1 to 15 above, and 2-mercapto-4-butyrolactone was analyzed. The degradation rate was calculated. Furthermore, the color change of the test liquid on the 10th day after the standing was visually evaluated as compared with the test liquid immediately after preparation.
これらの結果およびテスト液のpHを表2に示す。 These results and the pH of the test solution are shown in Table 2.
表2より、2−メルカプト−4−ブチロラクトンの配合量を多くした場合でも、実施例16〜30のテスト液は、比較例2のテスト液と比較して、40℃で10日間経過した後でも2−メルカプト−4−ブチロラクトンの分解が抑制され、着色が防止されている上に、臭気も改善されていることが分かる。 From Table 2, even when the compounding amount of 2-mercapto-4-butyrolactone was increased, the test solutions of Examples 16 to 30 were compared with the test solution of Comparative Example 2 even after 10 days at 40 ° C. It can be seen that the decomposition of 2-mercapto-4-butyrolactone is suppressed, coloring is prevented, and odor is also improved.
[実施例31〜34]
上記実施例1,6,9,10の分解率テスト後のテスト液をパーマネントウエーブ用第1液として用い、さらに下記パーマネントウエーブ用第2液を用いて、下記の方法でパーマネントウエーブ処理を行いパーマ性能への影響を確認した。
パーマネントウエーブ用第1液
表1に記載の実施例1,6,9,10の分解率テスト後のテスト液をパーマネントウエーブ用第1液として使用した。
パーマネントウエーブ用第2液の調製
臭素酸ナトリウム5g、および精製水95gを混合してパーマネントウエーブ用第2液を得た。
パーマネントウエーブ処理
ウエーブ効率は、フレグランスジャーナル臨時増刊(1984年、No.5、442ページ)記載の方法に従い、キルビー法により評価した。
[Examples 31 to 34]
Using the test solution after the decomposition rate test of Examples 1, 6, 9, and 10 as the first liquid for permanent wave, and further using the second liquid for permanent wave as described below, permanent wave treatment was performed by the following method. The effect on performance was confirmed.
First liquid for permanent wave The test liquid after the decomposition rate test of Examples 1, 6, 9, and 10 shown in Table 1 was used as the first liquid for permanent wave.
Preparation of second liquid for permanent wave 5 g of sodium bromate and 95 g of purified water were mixed to obtain a second liquid for permanent wave.
Permanent wave treatment wave efficiency was evaluated by the Kilby method according to the method described in the special issue of fragrance journal (1984, No. 5, page 442).
まず、中国人毛髪(長さ約20cm)をキルビーの器具に固定した。33℃に加温した上記パーマネントウエーブ用第1液に固定した毛髪を20分間浸した。その処理後に第1液から取り出した毛髪から液が滴らない程度に軽く拭き取りとった。 First, Chinese hair (about 20 cm in length) was fixed to a Kilby instrument. The hair fixed in the first liquid for permanent wave heated to 33 ° C. was soaked for 20 minutes. After the treatment, the hair taken out from the first liquid was wiped lightly to such an extent that the liquid did not drip.
この毛髪に上記パーマネントウエーブ用第2液を湿潤させて、25℃で10分間放置した。第2液による上記処理が完了した後に、流水を用いて毛髪を洗浄し、キルビーの器具から毛髪を外した後、毛髪を乾燥した。このようにして得られた乾燥毛髪の採寸を行い、下記ウエーブ効率計算式によりウエーブ効率を算出した。 The second liquid for permanent wave was moistened on the hair and allowed to stand at 25 ° C. for 10 minutes. After the above-described treatment with the second liquid was completed, the hair was washed with running water, the hair was removed from the kilbies, and the hair was dried. The dry hair thus obtained was measured, and the wave efficiency was calculated by the following wave efficiency calculation formula.
ウエーブ効率(%)=100−[100×(B−A)]÷(C−A)
A:キルビー器具の1番目と6番目の棒の間隔(棒の中心点を実測)(mm)
B:カールした毛髪の6山の長さ(mm)
C:カールした毛髪を直線に伸ばした時の6山分の長さ(mm)
このようにして得られたウエーブ効率の結果をX2とした(上記実施例1,6,9,10の分解率テスト後のテスト液を使用)。さらに上記実施例1,6,9,10の調製直後のテスト液を用いたほかは同様にしてこれらのウエーブ効率を求め、その結果をX1とした。
Wave efficiency (%) = 100− [100 × (B−A)] ÷ (C−A)
A: Distance between the first and sixth rods of the kirby apparatus (actual measurement of the center point of the rods) (mm)
B: Length of 6 piles of curled hair (mm)
C: Length of 6 mountains when curled hair is straightened (mm)
The result of the wave efficiency obtained in this way was defined as X2 (using the test solution after the decomposition rate test in Examples 1, 6, 9, and 10 above). Further, the wave efficiencies were determined in the same manner except that the test solutions immediately after preparation of Examples 1, 6, 9, and 10 were used, and the result was designated as X1.
上記X1とX2より、以下の式を用いてウエーブ効率の低下率を算出した。算出した結果を表3に示す。
ウエーブ効率の低下率(%)=[(X1−X2)/X1]×100
[比較例3]
比較例1で用いた分解率テスト後のテスト液をパーマネントウエーブ用第1液として使用したほかは、実施例31〜34と同様にしてパーマネントウエーブ処理を行い、ウエーブ効率X2を算出した。さらに上記比較例1の調製直後のテスト液を用いたほかは同様にしてウエーブ効率を求め、その結果をX1とした。
From the above X1 and X2, the reduction rate of the wave efficiency was calculated using the following formula. The calculated results are shown in Table 3.
Decrease rate of wave efficiency (%) = [(X1−X2) / X1] × 100
[Comparative Example 3]
Permanent wave treatment was performed in the same manner as in Examples 31 to 34 except that the test liquid after the decomposition rate test used in Comparative Example 1 was used as the first liquid for permanent wave, and the wave efficiency X2 was calculated. Further, the wave efficiency was determined in the same manner except that the test solution immediately after preparation of Comparative Example 1 was used, and the result was designated as X1.
これらX1およびX2を使用して、実施例31〜34と同様にしてウエーブ効率の低下率を算出した。その結果を表3に示す。 Using these X1 and X2, the rate of decrease in wave efficiency was calculated in the same manner as in Examples 31-34. The results are shown in Table 3.
表3より、実施例31〜34のテスト液によれば、経時後も2−メルカプト−4−ブチロラクトンの分解が抑えられているため、調製直後のテスト液と比較した場合でも毛髪に対するウエーブ効率の低下率が低いことが分かる。したがって、これらのテスト液は、比較例3のテスト液と比較して、パーマネントウエーブ加工薬剤としてより長く使用可能である。 From Table 3, according to the test liquids of Examples 31 to 34, the degradation of 2-mercapto-4-butyrolactone was suppressed even after aging, so that even when compared with the test liquid immediately after the preparation, the wave efficiency of the hair was improved. It can be seen that the rate of decline is low. Therefore, these test solutions can be used longer as permanent waving agents than the test solution of Comparative Example 3.
Claims (15)
素原子または硫黄原子を示す。Rはメルカプト基を有してもよい二価の有機残基を示す。)。 A hair treatment agent comprising a compound represented by the following formula (1), a surfactant, and water and emulsified;
とする請求項1に記載の毛髪処理用薬剤。 The hair treatment agent according to claim 1, wherein X in the formula (1) is —O—, —NH—, —NCH 3 — or —S—.
2−メルカプト−4−ブチロラクトン、2−メルカプト−4−メチル−4−ブチロラクトン、2−メルカプト−4−エチル−4−ブチロラクトンおよび2−メルカプト−6−ヘキサノラクタムからなる群から選ばれる少なくとも1種であることを特徴とする請求項1に記載の毛髪処理用薬剤。 The compound represented by the formula (1) is
At least one selected from the group consisting of 2-mercapto-4-butyrolactone, 2-mercapto-4-methyl-4-butyrolactone, 2-mercapto-4-ethyl-4-butyrolactone and 2-mercapto-6-hexanolactam The hair treatment agent according to claim 1, wherein
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005087141A JP4536562B2 (en) | 2005-03-24 | 2005-03-24 | Emulsified hair treatment agent |
CN2005800436467A CN101083975B (en) | 2004-12-20 | 2005-12-20 | Hair processing agent and method for permanent waving hair |
EP05820372.0A EP1827370B1 (en) | 2004-12-20 | 2005-12-20 | Hair processing agent and method for permanent waving hair |
PCT/JP2005/023834 WO2006068276A1 (en) | 2004-12-20 | 2005-12-20 | Hair processing agent and method for permanent waving hair |
TW094145330A TW200637595A (en) | 2004-12-20 | 2005-12-20 | Hair treating agent and method for permanent waving hair |
CN2009101719124A CN101669887B (en) | 2004-12-20 | 2005-12-20 | Hair processing agent and method for permanent waving hair |
KR1020077016845A KR100905733B1 (en) | 2004-12-20 | 2005-12-20 | Hair processing agent and method for permanent waving hair |
AU2005320058A AU2005320058B2 (en) | 2004-12-20 | 2005-12-20 | Hair processing agent and method for permanent waving hair |
ES05820372.0T ES2460865T3 (en) | 2004-12-20 | 2005-12-20 | Hair treatment agent and procedure for permanent hair waving |
US11/792,828 US8961946B2 (en) | 2004-12-20 | 2005-12-20 | Hair processing agent and method for permanent waving hair |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005087141A JP4536562B2 (en) | 2005-03-24 | 2005-03-24 | Emulsified hair treatment agent |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2006265187A true JP2006265187A (en) | 2006-10-05 |
JP4536562B2 JP4536562B2 (en) | 2010-09-01 |
Family
ID=37201521
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005087141A Active JP4536562B2 (en) | 2004-12-20 | 2005-03-24 | Emulsified hair treatment agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4536562B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006328008A (en) * | 2005-05-27 | 2006-12-07 | Showa Denko Kk | Permanently hair-waving agent containing heterocyclic mercapto compound |
US8153109B2 (en) | 2006-11-21 | 2012-04-10 | San-Ei Kagaku Co., Ltd. | Alkylene carbonate dilution, alkylene carbonate for preparing the dilution, and aqueous reducing chemical agent |
WO2018008653A1 (en) * | 2016-07-05 | 2018-01-11 | 株式会社カネカ | Emulsified composition and cosmetic using same |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4722764B2 (en) * | 2005-05-12 | 2011-07-13 | 昭和電工株式会社 | Permanent wave processing chemicals |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0597800A (en) * | 1991-10-11 | 1993-04-20 | Kao Corp | Mercapto-modified lactam derivative and hair treating agent composition containing the same |
-
2005
- 2005-03-24 JP JP2005087141A patent/JP4536562B2/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0597800A (en) * | 1991-10-11 | 1993-04-20 | Kao Corp | Mercapto-modified lactam derivative and hair treating agent composition containing the same |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006328008A (en) * | 2005-05-27 | 2006-12-07 | Showa Denko Kk | Permanently hair-waving agent containing heterocyclic mercapto compound |
JP4722561B2 (en) * | 2005-05-27 | 2011-07-13 | 昭和電工株式会社 | Permanent hair processing agent containing heterocyclic mercapto compound |
US8153109B2 (en) | 2006-11-21 | 2012-04-10 | San-Ei Kagaku Co., Ltd. | Alkylene carbonate dilution, alkylene carbonate for preparing the dilution, and aqueous reducing chemical agent |
WO2018008653A1 (en) * | 2016-07-05 | 2018-01-11 | 株式会社カネカ | Emulsified composition and cosmetic using same |
JPWO2018008653A1 (en) * | 2016-07-05 | 2019-03-14 | 株式会社カネカ | Emulsified composition and cosmetics using the same |
Also Published As
Publication number | Publication date |
---|---|
JP4536562B2 (en) | 2010-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2005320058B2 (en) | Hair processing agent and method for permanent waving hair | |
EP2961375B1 (en) | Composition and process for semi-permanent straightening of the hair | |
JP2016539933A (en) | Semi-permanent hair straightening composition and method | |
US20120174940A1 (en) | Hair treatment composition | |
CN110958875B (en) | Hair treatment comprising polyorganosiloxane with polyhydroxy aromatic moieties | |
JP4611105B2 (en) | Hair treatment agents containing peptides | |
KR100905620B1 (en) | Hair relaxer | |
ES2226086T3 (en) | REDUCING AGENT OF MULTIPLE COMPONENTS AND PERMANENT HAIR DEFORMATION PROCEDURE THAT USES IT. | |
JP2004315820A (en) | N-alpha- AND N-epsilon-LYSINE AND ORNITHINE DERIVATIVE CONTAINING THIOL FUNCTIONAL GROUP, AND COSMETIC USE OF THE SAME | |
JP2656215B2 (en) | Permanent reshaping method of hair and composition for beauty hair used in the method | |
JP4536562B2 (en) | Emulsified hair treatment agent | |
JP4249177B2 (en) | Permanent wave processing chemicals | |
JP4896447B2 (en) | Permanent hair processing agent | |
CN110996889A (en) | Aqueous composition for hair treatment | |
JP4519692B2 (en) | Hair treatment agent | |
JP4722561B2 (en) | Permanent hair processing agent containing heterocyclic mercapto compound | |
JP4963554B2 (en) | 1st agent composition for perm | |
WO2003086335A1 (en) | Hair care composition for restoring the elasticity of hair | |
JP4907185B2 (en) | Shampoo, conditioner, hair treatment, hair water, hair wax, hair mousse or hair gel | |
JP2009132652A (en) | Hair treatment agent containing mercapto compound | |
JP4583989B2 (en) | Permanent wave processing agent preparation set and permanent wave processing agent preparation method using the same | |
JP5126777B2 (en) | Hair treatment agent containing a mercapto compound | |
JP2009019012A (en) | Hair treatment agent containing mercapto compound | |
JP6902829B2 (en) | First agent for hair deformation, hair deformation agent and hair deformation method | |
JP2019059796A (en) | Hair treatment agent and hair permeation promoter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070126 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100209 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100312 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20100312 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100608 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100616 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130625 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4536562 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160625 Year of fee payment: 6 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |